Clicky

Friday, November 20, 2026
All public companies · Official EDGAR

RKTORocket One Inc.

Nasdaq · CIK 0001711786
Filer categoryNon-accelerated filer<br>Smaller reporting company
Entity typeoperating
SIC2834 Pharmaceutical Preparations
FY end1231
XBRL facts395

Identity from submissions API

NameRocket One Inc.
CIK0001711786
TickersRKTO
ExchangesNasdaq
Entity typeoperating
CategoryNon-accelerated filer<br>Smaller reporting company
SIC2834 Pharmaceutical Preparations
EIN821553794
LEI—
Fiscal year end1231
State of incorporationNV NV
Phone(866) 239-7459
Website—
Investor website—
Owner org03 Life Sciences
Flags—
Description—
Insider transactions (issuer)1
Insider transactions (owner)0

Former names

  • Hoth Therapeutics, Inc. (2017-07-14T00:00:00.000Z → 2026-05-27T00:00:00.000Z)
Business address
720 MONROE STREET
SUITE E514
HOBOKEN
NJ
07030
NJ
Mailing address
720 MONROE STREET
SUITE E514
HOBOKEN
NJ
07030
NJ

EDGAR has no company-logo API. Website field is shown when the filer provided one.

Financialist coverage

SEC filings

353 filing rows loaded from submissions recent.

FiledFormDocumentItemsAccessionFile no.FilmActSizeXBRLiXBRL
2026-11-13 10-Q QUARTERLY REPORT 0001213900-26-119676 001-38803 261552377 34 7192634 1 1
2026-10-23 ARS FORM ARS 0001213900-26-112122 001-38803 261482414 34 1083690
2026-10-23 DEFA14A DEFINITIVE ADDITIONAL MATERIALS 0001213900-26-112111 001-38803 261482305 34 1067075
2026-10-23 DEF 14A DEFINITIVE PROXY STATEMENT 0001213900-26-112099 001-38803 261482211 34 2375605 1 1
2026-10-02 PRE 14A PRELIMINARY PROXY STATEMENT 0001213900-26-106478 001-38803 261437621 34 1188314
2026-09-25 8-K CURRENT REPORT 5.08,8.01 0001213900-26-103530 001-38803 261410775 34 190991 1 1
2026-09-22 8-K CURRENT REPORT 8.01,9.01 0001213900-26-102217 001-38803 261397233 34 209039 1 1
2026-08-14 10-Q QUARTERLY REPORT 0001213900-26-090048 001-38803 261281420 34 5961792 1 1
2026-08-11 8-K CURRENT REPORT 3.01,8.01 0001213900-26-087771 001-38803 261263128 34 209364 1 1
2026-07-31 8-K CURRENT REPORT 8.01,9.01 0001213900-26-083962 001-38803 261228464 34 225062 1 1
2026-07-31 424B5 PROSPECTUS SUPPLEMENT 0001213900-26-083959 333-291566 261228433 33 8887
2026-07-21 8-K CURRENT REPORT 8.01,9.01 0001213900-26-079817 001-38803 261188194 34 21549065 1 1
2026-06-25 8-K CURRENT REPORT 8.01,9.01 0001213900-26-072137 001-38803 261122995 34 205468 1 1
2026-06-03 8-K CURRENT REPORT 8.01,9.01 0001213900-26-064460 001-38803 261059011 34 209288 1 1
2026-06-03 8-K CURRENT REPORT 8.01,9.01 0001213900-26-064457 001-38803 261059009 34 222197 1 1
2026-06-03 424B5 PROSPECTUS SUPPLEMENT 0001213900-26-064456 333-291566 261059007 33 8687
2026-06-02 8-K CURRENT REPORT 8.01,9.01 0001213900-26-064177 001-38803 261056204 34 203943 1 1
2026-05-28 4 xslF345X06/ownership.xml 0001213900-26-062135 5649
2026-05-28 4 xslF345X06/ownership.xml 0001213900-26-062134 5689
2026-05-28 4 xslF345X06/ownership.xml 0001213900-26-062133 5637
2026-05-28 4 xslF345X06/ownership.xml 0001213900-26-062131 5674
2026-05-28 4 xslF345X06/ownership.xml 0001213900-26-062128 5643
2026-05-28 8-K CURRENT REPORT 8.01,9.01 0001213900-26-061789 001-38803 261028655 34 237499 1 1
2026-05-27 424B5 PROSPECTUS SUPPLEMENT 0001213900-26-061613 333-291566 261027680 33 9023
2026-05-27 8-K CURRENT REPORT 5.03,8.01,9.01 0001213900-26-061252 001-38803 261022249 34 1666581 1 1
2026-05-21 8-K CURRENT REPORT 1.01,8.01,9.01 0001213900-26-060075 001-38803 261008868 34 469986 1 1
2026-05-15 10-Q QUARTERLY REPORT 0001213900-26-057726 001-38803 26987173 34 4717048 1 1
2026-05-06 8-K CURRENT REPORT 8.01 0001213900-26-052803 001-38803 26948351 34 197608 1 1
2026-05-04 8-K CURRENT REPORT 3.01 0001213900-26-051728 001-38803 26939264 34 191557 1 1
2026-04-16 8-K CURRENT REPORT 8.01,9.01 0001213900-26-044741 001-38803 26868549 34 226086 1 1
2026-04-16 424B5 PROSPECTUS SUPPLEMENT 0001213900-26-044740 333-291566 26868543 33 456305
2026-04-02 8-K CURRENT REPORT 1.01,3.02,8.01,9.01 0001213900-26-039363 001-38803 26833824 34 835881 1 1
2026-04-02 424B5 PROSPECTUS SUPPLEMENT 0001213900-26-039103 333-291566 26832026 33 456713
2026-03-27 10-K ANNUAL REPORT 0001213900-26-035625 001-38803 26808293 34 6900472 1 1
2026-01-16 8-K CURRENT REPORT 8.01,9.01 0001213900-26-004899 001-38803 26537680 34 9298727 1 1
2025-12-04 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-25-003543 333-291566 251551092 33 1793
2025-12-02 CORRESP filename1.htm 0001213900-25-117325 6125
2025-11-17 S-3 REGISTRATION STATEMENT 0001213900-25-111082 333-291566 251488405 33 1385248 1 1
2025-11-13 424B5 PROSPECTUS SUPPLEMENT 0001213900-25-109813 333-272620 251476966 33 25125
2025-11-12 10-Q QUARTERLY REPORT 0001213900-25-109220 001-38803 251472993 34 5653443 1 1
2025-10-17 8-K CURRENT REPORT 8.01,9.01 0001213900-25-099969 001-38803 251401021 34 14448618 1 1
2025-09-12 8-K CURRENT REPORT 8.01 0001213900-25-087054 001-38803 251310084 34 201762 1 1
2025-08-28 4 xslF345X05/ownership.xml 0001213900-25-081945 6389
2025-08-22 8-K CURRENT REPORT 5.02,8.01,9.01 0001213900-25-079915 001-38803 251246476 34 364624 1 1
2025-08-12 10-Q QUARTERLY REPORT 0001213900-25-074968 001-38803 251206903 34 5024805 1 1
2025-08-05 S-8 REGISTRATION STATEMENT 0001213900-25-072108 333-289260 251185369 33 214042 1 1
2025-08-05 8-K CURRENT REPORT 5.07 0001213900-25-072068 001-38803 251184881 34 207403 1 1
2025-06-24 8-K CURRENT REPORT 7.01,9.01 0001213900-25-057233 001-38803 251068994 34 13275818 1 1
2025-06-20 8-K CURRENT REPORT 8.01,9.01 0001213900-25-055834 001-38803 251059114 34 203600 1 1
2025-06-16 ARS FORM ARS 0001213900-25-054768 001-38803 251050244 34 1160978
2025-06-16 DEFA14A DEFINITIVE ADDITIONAL MATERIALS 0001213900-25-054764 001-38803 251050178 34 1715050
2025-06-16 DEF 14A DEFINITIVE PROXY STATEMENT 0001213900-25-054759 001-38803 251050089 34 3266654 1 1
2025-06-09 8-K CURRENT REPORT 8.01,9.01 0001213900-25-052295 001-38803 251032754 34 17239230 1 1
2025-05-21 3 xslF345X02/ownership.xml 0001213900-25-046516 9205
2025-05-16 8-K CURRENT REPORT 3.01 0001213900-25-044894 001-38803 25959422 34 200053 1 1
2025-05-12 10-Q QUARTERLY REPORT 0001213900-25-042043 001-38803 25935069 34 4619399 1 1
2025-05-02 8-K CURRENT REPORT 8.01 0001213900-25-038694 001-38803 25905570 34 196896 1 1
2025-04-15 8-K CURRENT REPORT 5.02,8.01,9.01 0001213900-25-031763 001-38803 25837673 34 227054 1 1
2025-03-28 10-K ANNUAL REPORT 0001013762-25-004108 001-38803 25786481 34 10515346 1 1
2025-03-25 8-K CURRENT REPORT 1.01,4.02,9.01 0001013762-25-002271 001-38803 25769411 34 288954 1 1
2025-02-07 8-K CURRENT REPORT 8.01,9.01 0001213900-25-011325 001-38803 25601996 34 245594 1 1
2025-02-07 424B5 PROSPECTUS SUPPLEMENT 0001213900-25-011320 333-272620 25601911 33 25042
2025-01-24 8-K CURRENT REPORT 8.01,9.01 0001213900-25-006526 001-38803 25554400 34 258564 1 1
2025-01-15 4 xslF345X05/ownership.xml 0001213900-25-003838 7826
2025-01-15 4 xslF345X05/ownership.xml 0001213900-25-003835 5747
2024-12-02 8-K CURRENT REPORT 8.01,9.01 0001213900-24-104567 001-38803 241519227 34 8971157 1 1
2024-11-20 8-K CURRENT REPORT 8.01,9.01 0001213900-24-100368 001-38803 241478349 34 217804 1 1
2024-11-12 10-Q QUARTERLY REPORT 0001213900-24-096778 001-38803 241447967 34 5277762 1 1
2024-11-12 424B5 PROSPECTUS SUPPLEMENT 0001213900-24-096015 333-272620 241442268 33 493504
2024-11-08 8-K CURRENT REPORT 1.01,9.01 0001213900-24-096007 001-38803 241441996 34 497185 1 1
2024-11-01 8-K CURRENT REPORT 3.01 0001213900-24-093514 001-38803 241419281 34 200958 1 1
2024-08-21 4 xslF345X05/ownership.xml 0001213900-24-071462 5428
2024-08-21 4 xslF345X05/ownership.xml 0001213900-24-071463 7840
2024-08-21 4 xslF345X05/ownership.xml 0001213900-24-071461 5422
2024-08-21 4 xslF345X05/ownership.xml 0001213900-24-071460 5474
2024-08-21 4 xslF345X05/ownership.xml 0001213900-24-071459 5434
2024-08-19 4 xslF345X05/ownership.xml 0001213900-24-070415 4596
2024-08-16 S-8 REGISTRATION STATEMENT 0001213900-24-070249 333-281610 241216899 33 93193
2024-08-09 10-Q QUARTERLY REPORT 0001213900-24-067131 001-38803 241192579 34 4880133 1 1
2024-08-07 8-K CURRENT REPORT 5.07 0001213900-24-066130 001-38803 241183963 34 209535 1 1
2024-06-18 ARS FORM ARS 0001213900-24-053508 001-38803 241050125 34 954719
2024-06-18 DEFA14A DEFINITIVE ADDITIONAL MATERIALS 0001213900-24-053505 001-38803 241050120 34 4149772
2024-06-18 DEF 14A DEFINITIVE PROXY STATEMENT 0001213900-24-053502 001-38803 241050117 34 876205
2024-06-17 8-K CURRENT REPORT 5.03,9.01 0001213900-24-053359 001-38803 241048876 34 211062 1 1
2024-05-14 10-Q QUARTERLY REPORT 0001213900-24-042906 001-38803 24944046 34 4124535 1 1
2024-04-22 424B3 PROSPECTUS 0001213900-24-034927 333-278620 24861374 33 854739
2024-04-19 EFFECT xslEFFECTX01/primary_doc.xml S-1,,2024-04-19 17:00:00 9999999995-24-001054 333-278620 24859426 33 1761
2024-04-18 CORRESP filename1.htm 0001213900-24-034103 5683
2024-04-17 UPLOAD filename1.pdf 0000000000-24-004181 333-278620 40293
2024-04-11 S-1 REGISTRATION STATEMENT 0001213900-24-032207 333-278620 24838712 33 999665
2024-03-28 10-K ANNUAL REPORT 0001213900-24-027213 001-38803 24798888 34 6350294 1 1
2024-03-28 424B3 PROSPECTUS SUPPLEMENT 0001213900-24-026878 333-269224 24793480 33 14910
2024-03-28 8-K CURRENT REPORT 1.01,3.02,8.01,9.01 0001213900-24-026868 001-38803 24793429 34 433527 1 1
2024-02-14 SC 13G/A armistice-hoth123123a1.htm 0001172661-24-001269 005-91443 24636289 34 90660
2024-01-09 8-K CURRENT REPORT 8.01 0001213900-24-002248 001-38803 24523007 34 198092 1 1
2024-01-08 4 xslF345X05/ownership.xml 0001213900-24-001960 7782
2024-01-08 4 xslF345X05/ownership.xml 0001213900-24-001959 5363
2024-01-08 4 xslF345X05/ownership.xml 0001213900-24-001958 5369
2024-01-08 4 xslF345X05/ownership.xml 0001213900-24-001955 5375
2024-01-08 4 OWNERSHIP DOCUMENT 0001213900-24-001954 5447
2023-11-13 10-Q QUARTERLY REPORT 0001213900-23-086133 001-38803 231398974 34 3715781 1 1
2023-10-05 8-K CURRENT REPORT 8.01,9.01 0001013762-23-002005 001-38803 231309859 34 5545979 1 1
2023-09-15 8-K CURRENT REPORT 1.01,3.02,8.01,9.01 0001213900-23-077030 001-38803 231258934 34 910905 1 1
2023-09-14 424B5 PROSPECTUS SUPPLEMENT 0001213900-23-076751 333-272620 231255954 33 491353
2023-08-21 8-K CURRENT REPORT 5.07 0001213900-23-069494 001-38803 231189946 34 211308 1 1
2023-08-21 S-8 REGISTRATION STATEMENT 0001213900-23-069462 333-274125 231189852 33 300659
2023-08-17 8-K CURRENT REPORT 8.01,9.01 0001213900-23-068330 001-38803 231179624 34 4939899 1 1
2023-08-11 10-Q QUARTERLY REPORT 0001213900-23-066246 001-38803 231164298 34 3392010 1 1
2023-07-18 4 xslF345X05/ownership.xml 0001213900-23-057862 5279
2023-07-18 4 xslF345X05/ownership.xml 0001213900-23-057861 7695
2023-07-18 4 xslF345X05/ownership.xml 0001213900-23-057860 5331
2023-07-18 4 xslF345X05/ownership.xml 0001213900-23-057859 5285
2023-07-18 4 xslF345X05/ownership.xml 0001213900-23-057864 5291
2023-06-27 DEFA14A DEFINITIVE ADDITIONAL MATERIALS 0001213900-23-052148 001-38803 231047579 34 1543130
2023-06-27 DEF 14A DEFINITIVE PROXY STATEMENT 0001213900-23-052141 001-38803 231047566 34 1666172
2023-06-16 EFFECT xslEFFECTX01/primary_doc.xml S-3,,2023-06-16 16:00:00 9999999995-23-001783 333-272620 231023189 33 1690
2023-06-15 UPLOAD filename1.pdf 0000000000-23-006491 40212
2023-06-15 CORRESP filename1.htm 0001213900-23-049254 6101
2023-06-13 S-3 REGISTRATION STATEMENT 0001213900-23-048616 333-272620 231012016 33 971177
2023-06-06 8-K CURRENT REPORT 8.01 0001213900-23-046791 001-38803 23996310 34 199948 1 1
2023-05-15 10-Q QUARTERLY REPORT 0001213900-23-039789 001-38803 23922611 34 3291412 1 1
2023-03-31 10-K ANNUAL REPORT 0001213900-23-025455 001-38803 23787579 34 6021444 1 1
2023-02-28 8-K CURRENT REPORT 8.01 0001213900-23-015045 001-38803 23678836 34 199417 1 1
2023-02-14 SC 13G armistice-hoth123122.htm 0001172661-23-001116 005-91443 23625983 34 90461
2023-02-08 SC 13G/A AMENDMENT NO. 2 TO SCHEDULE 13G 0001213900-23-009119 005-91443 23596952 34 61904
2023-01-26 424B3 PROSPECTUS 0001213900-23-005327 333-269224 23557703 33 295397
2023-01-25 EFFECT xslEFFECTX01/primary_doc.xml S-3,,2023-01-25 17:00:00 9999999995-23-000183 333-269224 23553801 33 1689
2023-01-23 CORRESP filename1.htm 0001213900-23-004444 6192
2023-01-23 UPLOAD filename1.pdf 0000000000-23-000707 40154
2023-01-13 S-3 REGISTRATION STATEMENT 0001213900-23-002795 333-269224 23528946 33 416916
2023-01-04 D xslFormDX01/primary_doc.xml 06b 0001213900-23-000912 021-469705 23508023 33 10863
2023-01-04 UPLOAD filename1.pdf 0000000000-23-000074 39695
2023-01-03 CORRESP filename1.htm 0001213900-23-000426 20218
2022-12-30 8-K CURRENT REPORT 1.01,3.02,8.01,9.01 0001213900-22-084039 001-38803 221502142 34 1099383 1 1
2022-12-13 4 xslF345X03/ownership.xml 0001213900-22-079538 4823
2022-12-13 3 xslF345X02/ownership.xml 0001213900-22-079531 9535
2022-12-13 8-K CURRENT REPORT 5.02,5.03,5.07,9.01 0001213900-22-079522 001-38803 221460053 34 1213563 1 1
2022-12-07 UPLOAD filename1.pdf 0000000000-22-013210 43879
2022-11-14 DEFA14A DEFINITIVE ADDITIONAL MATERIALS 0001213900-22-072312 001-38803 221386707 34 356748
2022-11-14 DEF 14A DEFINITIVE PROXY STATEMENT 0001213900-22-072285 001-38803 221386355 34 489997
2022-11-10 10-Q QUARTERLY REPORT 0001213900-22-071279 001-38803 221378241 34 3463686 1 1
2022-11-10 8-K CURRENT REPORT 8.01,9.01 0001213900-22-070825 001-38803 221375018 34 222820 1 1
2022-11-03 PRE 14A PRELIMINARY PROXY STATEMENT 0001213900-22-068990 001-38803 221358344 34 133188
2022-11-03 8-K CURRENT REPORT 1.01,3.02,5.03,9.01 0001213900-22-068985 001-38803 221358204 34 275939 1 1
2022-10-24 8-K CURRENT REPORT 5.03,8.01,9.01 0001213900-22-065860 001-38803 221326417 34 648357 1 1
2022-09-20 4 xslF345X03/ownership.xml 0001213900-22-057162 4464
2022-09-19 4 xslF345X03/ownership.xml 0001213900-22-056813 4464
2022-08-22 8-K CURRENT REPORT 5.03,9.01 0001213900-22-050061 001-38803 221183910 34 210984 1 1
2022-08-12 10-Q QUARTERLY REPORT 0001213900-22-047409 001-38803 221160317 34 3203087 1 1
2022-07-18 8-K CURRENT REPORT 8.01,9.01 0001213900-22-039788 001-38803 221088170 34 2324217 1 1
2022-07-01 8-K CURRENT REPORT 3.01 0001213900-22-036699 001-38803 221061692 34 200370 1 1
2022-07-01 S-8 REGISTRATION STATEMENT 0001213900-22-036696 333-265984 221061602 33 92805
2022-06-23 8-K CURRENT REPORT 5.07 0001213900-22-034635 001-38803 221036166 34 223518 1 1
2022-06-13 8-K CURRENT REPORT 8.01,9.01 0001213900-22-032370 001-38803 221010800 34 3565492 1 1
2022-05-12 10-Q QUARTERLY REPORT 0001213900-22-025987 001-38803 22918573 34 2787238 1 1
2022-04-29 8-K CURRENT REPORT 8.01,9.01 0001213900-22-022734 001-38803 22875662 34 7249634 1 1
2022-04-27 DEFA14A DEFINITIVE ADDITIONAL MATERIALS 0001213900-22-021770 001-38803 22856267 34 502531
2022-04-27 DEF 14A DEFINITIVE PROXY STATEMENT 0001213900-22-021768 001-38803 22856256 34 829221
2022-04-13 424B5 PROSPECTUS SUPPLEMENT 0001213900-22-019649 333-236887 22825406 33 615115
2022-04-13 8-K CURRENT REPORT 1.01,8.01,9.01 0001213900-22-019647 001-38803 22825344 34 542048 1 1
2022-04-11 424B5 PRELIMINARY PROSPECTUS SUPPLEMENT 0001213900-22-019243 333-236887 22820568 33 617705
2022-04-05 8-K CURRENT REPORT 8.01 0001213900-22-018023 001-38803 22805237 34 199862 1 1
2022-04-04 PRE 14A PRELIMINARY PROXY STATEMENT 0001213900-22-017823 001-38803 22802354 34 1015605
2022-03-30 10-K ANNUAL REPORT 0001213900-22-015909 001-38803 22782496 34 5567590 1 1
2022-03-18 4 xslF345X03/ownership.xml 0001213900-22-013591 5303
2022-03-18 4 xslF345X03/ownership.xml 0001213900-22-013590 5279
2022-03-18 4 xslF345X03/ownership.xml 0001213900-22-013589 5251
2022-03-18 4 xslF345X03/ownership.xml 0001213900-22-013588 7669
2022-03-18 4 xslF345X03/ownership.xml 0001213900-22-013587 5263
2022-02-23 SC 13G/A c103098_sc13ga.htm 0000930413-22-000317 005-91443 22664201 34 43973
2022-02-11 SC 13G/A AMENDMENT NO. 1 TO SCHEDULE 13G 0001213900-22-006678 005-91443 22616669 34 43774
2022-02-09 SC 13G/A sc13g.htm 0000929638-22-000310 005-91443 22608064 34 68903
2022-02-04 S-8 REGISTRATION STATEMENT 0001213900-22-005506 333-262530 22593726 33 252892
2022-02-03 SC 13G/A SC 13G/A 0001753926-22-000140 005-91443 22588092 34 64066
2022-01-21 8-K CURRENT REPORT 5.02,9.01 0001213900-22-003061 001-38803 22546110 34 197987 1 1
2022-01-07 8-K CURRENT REPORT 8.01,9.01 0001213900-22-001035 001-38803 22516496 34 198388 1 1
2022-01-04 8-K CURRENT REPORT 3.01,8.01,9.01 0001213900-22-000376 001-38803 22504146 34 222369 1 1
2021-12-08 8-K CURRENT REPORT 8.01,9.01 0001213900-21-064089 001-38803 211477680 34 226270 1 1
2021-11-10 10-Q QUARTERLY REPORT 0001213900-21-058131 001-38803 211396823 34 3260319 1 1
2021-09-01 8-K CURRENT REPORT 8.01,9.01 0001213900-21-046146 001-38803 211230214 34 9233318 1 1
2021-08-26 8-K CURRENT REPORT 8.01 0001213900-21-044908 001-38803 211208887 34 200968 1 1
2021-08-11 10-Q QUARTERLY REPORT 0001213900-21-041662 001-38803 211163852 34 3258941 1 1
2021-06-30 8-K CURRENT REPORT 5.02,5.07,8.01,9.01 0001213900-21-035058 001-38803 211062320 34 97822
2021-06-21 8-K CURRENT REPORT 8.01 0001213900-21-033008 001-38803 211026177 34 24446
2021-05-24 8-K CURRENT REPORT 8.01,9.01 0001213900-21-028575 001-38803 21951243 34 6964184
2021-05-13 10-Q QUARTERLY REPORT 0001213900-21-026092 001-38803 21919849 34 2328223 1
2021-05-07 DEFR14A DEFINITIVE REVISED PROXY STATEMENT 0001213900-21-025190 001-38803 21904041 34 2220003
2021-05-07 DEF 14A DEFINITIVE PROXY STATEMENT 0001213900-21-025135 001-38803 21902877 34 2219785
2021-05-07 8-K CURRENT REPORT 8.01 0001213900-21-024999 001-38803 21900322 34 17200
2021-04-26 PRE 14A PRELIMINARY PROXY STATEMENT 0001213900-21-022924 001-38803 21855057 34 1215093
2021-04-15 8-K CURRENT REPORT 8.01 0001213900-21-021635 001-38803 21827328 34 18763
2021-04-06 424B3 PROSPECTUS 0001213900-21-020275 333-254638 21808058 33 414009
2021-04-05 EFFECT xslEFFECTX01/primary_doc.xml S-3,,2021-04-05 17:00:00 9999999995-21-001284 333-254638 21808029 33 1689
2021-03-30 CORRESP filename1.htm 0001213900-21-018688 5951
2021-03-29 UPLOAD filename1.pdf 0000000000-21-003758 40156
2021-03-23 S-3 REGISTRATION STATEMENT 0001213900-21-017330 333-254638 21765746 33 545879
2021-03-18 SC 13G c101332_sc13g.htm 0000930413-21-000593 005-91443 21753063 34 62446
2021-03-16 10-K ANNUAL REPORT 0001213900-21-015764 001-38803 21747180 34 4396445 1
2021-03-16 D xslFormDX01/primary_doc.xml 06b 0001213900-21-015712 021-392456 21745931 33 11930
2021-03-09 8-K CURRENT REPORT 1.01,3.02,8.01,9.01 0001213900-21-014156 001-38803 21724162 34 738944
2021-02-24 8-K CURRENT REPORT 8.01 0001213900-21-011260 001-38803 21668545 34 18569
2021-02-17 SC 13G SCHEDULE 13G 0001213900-21-009748 005-91443 21641349 34 49546
2021-02-16 5 OWNERSHIP DOCUMENT 0001213900-21-009746 5168
2021-02-16 4/A OWNERSHIP DOCUMENT 0001213900-21-009744 5006
2021-02-16 SC 13G/A AMENDMENT NO. 1 TO SCHEDULE 13G 0001213900-21-009684 005-91443 21640222 34 49713
2021-02-11 5 xslF345X03/ownership.xml 0001213900-21-008623 5094
2021-02-01 4 xslF345X03/ownership.xml 0001213900-21-005808 7669
2021-02-01 4 xslF345X03/ownership.xml 0001213900-21-005805 5250
2021-02-01 4 xslF345X03/ownership.xml 0001213900-21-005803 5311
2021-02-01 4 OWNERSHIP DOCUMENT 0001213900-21-005801 5294
2021-02-01 4 OWNERSHIP DOCUMENT 0001213900-21-005799 5334
2021-02-01 4 OWNERSHIP DOCUMENT 0001213900-21-005796 5312
2021-01-29 8-K FORM 8-K 5.02 0001213900-21-005372 001-38803 21571350 34 28031
2021-01-25 SC 13G sc13g.htm 0000929638-21-000095 005-91443 21550586 34 76413
2021-01-25 8-K CURRENT REPORT 8.01,9.01 0001213900-21-003890 001-38803 21547996 34 5253618
2021-01-19 424B3 PROSPECTUS 0001213900-21-002850 333-251994 21535775 33 285848
2021-01-15 EFFECT xslEFFECTX01/primary_doc.xml S-3,,2021-01-15 17:00:00 9999999995-21-000177 333-251994 21533679 33 1689
2021-01-13 SC 13G SCHEDULE 13G 0001213900-21-001969 005-91443 21526376 34 63744
2021-01-13 CORRESP filename1.htm 0001213900-21-001949 6221
2021-01-12 UPLOAD filename1.pdf 0000000000-21-000383 40162
2021-01-12 SC 13G SC 13G 0001753926-21-000009 005-91443 21522379 34 79036
2021-01-08 S-3 REGISTRATION STATEMENT 0001213900-21-001246 333-251994 21518316 33 368086
2021-01-08 D xslFormDX01/primary_doc.xml 06b 0001213900-21-001205 021-385744 21517800 33 11726
2021-01-08 8-K CURRENT REPORT 1.01,3.02,5.02,8.01,9.01 0001213900-21-001182 001-38803 21517683 34 611344
2020-12-08 8-K CURRENT REPORT 8.01 0001213900-20-041485 001-38803 201374425 34 25922
2020-11-10 10-Q QUARTERLY REPORT 0001213900-20-036191 001-38803 201301639 34 2926187 1
2020-09-21 8-K CURRENT REPORT 1.01,8.01,9.01 0001213900-20-027547 001-38803 201186465 34 236945
2020-09-11 8-K CURRENT REPORT 8.01 0001213900-20-026170 001-38803 201169969 34 17591
2020-09-09 3 xslF345X02/ownership.xml 0001213900-20-025860 10292
2020-08-31 8-K CURRENT REPORT 5.02,8.01,9.01 0001213900-20-024583 001-38803 201151773 34 122314
2020-08-18 8-K CURRENT REPORT 5.02 0001213900-20-022690 001-38803 201113889 34 17007
2020-08-13 10-Q QUARTERLY REPORT 0001213900-20-021878 001-38803 201099478 34 3297487 1
2020-08-10 8-K CURRENT REPORT 1.01,8.01,9.01 0001213900-20-021059 001-38803 201087352 34 41555
2020-08-05 8-K CURRENT REPORT 1.01,8.01,9.01 0001213900-20-020379 001-38803 201077423 34 300032
2020-07-23 4 OWNERSHIP DOCUMENT 0001213900-20-018414 5295
2020-07-23 4 OWNERSHIP DOCUMENT 0001213900-20-018411 5332
2020-07-23 4 xslF345X03/ownership.xml 0001213900-20-018410 7667
2020-07-23 4 OWNERSHIP DOCUMENT 0001213900-20-018409 5283
2020-07-23 4 xslF345X03/ownership.xml 0001213900-20-018408 5376
2020-07-23 4 xslF345X03/ownership.xml 0001213900-20-018407 5312
2020-07-21 SC 13G SCHEDULE 13G 0001213900-20-018167 005-91443 201039000 34 54376
2020-07-20 8-K CURRENT REPORT 8.01 0001213900-20-017874 001-38803 201035038 34 27705
2020-07-08 8-K CURRENT REPORT 8.01 0001213900-20-016921 001-38803 201017287 34 16929
2020-07-02 8-K CURRENT REPORT 1.01,5.07,8.01,9.01 0001213900-20-016495 001-38803 201007227 34 149947
2020-05-29 4 xslF345X03/ownership.xml 0001213900-20-013694 4351
2020-05-29 8-K CURRENT REPORT 1.01,9.01 0001213900-20-013642 001-38803 20924061 34 73379
2020-05-22 424B5 PROSPECTUS SUPPLEMENT 0001213900-20-013343 333-236887 20906446 33 756410
2020-05-22 8-K CURRENT REPORT 1.01,3.02,8.01,9.01 0001213900-20-013321 001-38803 20905830 34 421649
2020-05-21 424B5 PROSPECTUS SUPPLEMENT 0001213900-20-013240 333-236887 20902414 33 774237
2020-05-21 8-K FORM 8-K 8.01,9.01 0001213900-20-013226 001-38803 20901835 34 6883848
2020-05-19 DEF 14A DEFINITIVE PROXY STATEMENT 0001213900-20-012934 001-38803 20893832 34 1346179
2020-05-19 8-K CURRENT REPORT 1.01,9.01 0001213900-20-012878 001-38803 20891600 34 130559
2020-05-13 10-Q QUARTERLY REPORT 0001213900-20-012014 001-38803 20873687 34 2383965 1
2020-05-07 424B3 PROSPECTUS 0001213900-20-011222 333-237567 20854357 33 1819488
2020-05-06 EFFECT xslEFFECTX01/primary_doc.xml S-1,,2020-05-06 17:00:00 9999999995-20-001061 333-237567 20854336 33 1689
2020-05-05 CORRESP filename1.htm 0001213900-20-011027 7423
2020-05-05 S-1/A AMENDMENT NO.1 TO FORM S-1 0001213900-20-011025 333-237567 20849071 33 1930165
2020-04-17 4 xslF345X03/ownership.xml 0001213900-20-009453 4830
2020-04-17 8-K CURRENT REPORT 5.02,8.01,9.01 0001213900-20-009452 001-38803 20799956 34 45211
2020-04-17 3 xslF345X02/ownership.xml 0001213900-20-009449 8829
2020-04-16 4 xslF345X03/ownership.xml 0001213900-20-009344 4833
2020-04-10 UPLOAD filename1.pdf 0000000000-20-003134 39853
2020-04-03 S-1 REGISTRATION STATEMENT 0001213900-20-008546 333-237567 20773409 33 1983701
2020-03-25 424B5 PROSPECTUS SUPPLEMENT 0001213900-20-007361 333-236887 20742495 33 718493
2020-03-25 8-K CURRENT REPORT 1.01,3.02,8.01,9.01 0001213900-20-007353 001-38803 20742328 34 418051
2020-03-23 424B5 PROSPECTUS SUPPLEMENT 0001213900-20-007155 333-236887 20735635 33 720686
2020-03-23 8-K CURRENT REPORT 1.01,8.01,9.01 0001213900-20-007153 001-38803 20735606 34 248094
2020-03-11 EFFECT xslEFFECTX01/primary_doc.xml S-3,,2020-03-11 16:30:00 9999999995-20-000555 333-236887 20707073 33 1689
2020-03-09 CORRESP filename1.htm 0001213900-20-005745 7133
2020-03-09 UPLOAD filename1.pdf 0000000000-20-002104 45916
2020-03-04 SC 13G FORM SC 13G 0001213900-20-005418 005-91443 20688051 34 43431
2020-03-04 S-3 REGISTRATION STATEMENT 0001213900-20-005411 333-236887 20687653 33 1253324
2020-03-04 3 xslF345X02/ownership.xml 0001213900-20-005405 9376
2020-03-02 10-K ANNUAL REPORT 0001213900-20-005186 001-38803 20678336 34 7774354 1
2020-02-28 5 FORM 5 0001104659-20-026941 10986
2020-02-28 SC 13G SC 13G 0001104659-20-026927 005-91443 20667680 34 37297
2020-02-14 5 xslF345X03/ownership.xml 0001213900-20-003951 5104
2020-02-14 5 xslF345X03/ownership.xml 0001213900-20-003890 9004
2019-12-26 4 xslF345X03/ownership.xml 0001213900-19-027001 5251
2019-12-26 4 xslF345X03/ownership.xml 0001213900-19-027000 5376
2019-12-26 4 xslF345X03/ownership.xml 0001213900-19-026999 5312
2019-12-26 4 xslF345X03/ownership.xml 0001213900-19-026997 5303
2019-12-26 4 xslF345X03/ownership.xml 0001213900-19-026996 5235
2019-11-12 10-Q QUARTERLY REPORT 0001213900-19-022971 001-38803 191210708 34 2220666 1
2019-10-25 EFFECT xslEFFECTX01/primary_doc.xml S-1,,2019-10-25 17:00:00 9999999995-19-002397 333-233954 191171048 33 1690
2019-10-25 424B3 PROSPECTUS 0001213900-19-021178 333-233954 191170686 33 1730856
2019-10-23 S-1/A AMENDMENT NO. 1 TO S-1 0001213900-19-020936 333-233954 191164366 33 1891652
2019-10-23 CORRESP filename1.htm 0001213900-19-020939 7069
2019-10-23 CORRESP filename1.htm 0001213900-19-020932 8655
2019-10-21 8-K CURRENT REPORT 7.01,9.01 0001213900-19-020744 001-38803 191160033 34 9516618
2019-10-07 UPLOAD filename1.pdf 0000000000-19-014354 42366
2019-09-26 S-1 REGISTRATION STATEMENT 0001213900-19-019010 333-233954 191118132 33 1843107
2019-09-16 424B3 PROSPECTUS 0001213900-19-018153 333-233563 191095205 33 1836631
2019-09-13 EFFECT xslEFFECTX01/primary_doc.xml S-1,,2019-09-13 17:00:00 9999999995-19-002094 333-233563 191093576 33 1690
2019-09-12 CORRESP filename1.htm 0001213900-19-017814 5763
2019-09-11 S-1/A AMENDMENT TO FORM S-1 0001213900-19-017735 333-233563 191088509 33 2001729
2019-09-10 UPLOAD filename1.pdf 0000000000-19-013327 39846
2019-09-06 8-K CURRENT REPORT 7.01,9.01 0001213900-19-017375 001-38803 191080007 34 54282
2019-08-30 S-1 REGISTRATION STATEMENT 0001213900-19-017016 333-233563 191069629 33 1989071
2019-08-23 8-K CURRENT REPORT 1.01,5.02,8.01,9.01 0001213900-19-016599 001-38803 191049290 34 228925
2019-08-21 8-K CURRENT REPORT 1.01,3.02,9.01 0001213900-19-016473 001-38803 191043797 34 822887
2019-08-21 D xslFormDX01/primary_doc.xml 06b 0001213900-19-016442 021-347121 191043184 33 11778
2019-08-14 10-Q QUARTERLY REPORT 0001213900-19-015804 001-38803 191026498 34 1987532 1
2019-05-15 10-Q QUARTERLY REPORT 0001213900-19-008830 001-38803 19828538 34 1564207 1
2019-04-29 8-K CURRENT REPORT 7.01,9.01 0001213900-19-007320 001-38803 19777117 34 11359008
2019-04-01 10-K ANNUAL REPORT 0001213900-19-005307 001-38803 19718172 34 3878448 1
2019-03-07 4 xslF345X03/ownership.xml 0001213900-19-003749 5319
2019-03-07 3 xslF345X02/ownership.xml 0001213900-19-003746 9465
2019-03-07 8-K CURRENT REPORT 5.02,9.01 0001213900-19-003742 001-38803 19666217 34 49617
2019-03-04 4 OWNERSHIP DOCUMENT 0001213900-19-003530 6990
2019-03-04 4 xslF345X03/ownership.xml 0001213900-19-003528 7004
2019-03-04 3 xslF345X02/ownership.xml 0001213900-19-003526 5823
2019-03-04 3 xslF345X02/ownership.xml 0001213900-19-003524 6490
2019-03-04 3 xslF345X02/ownership.xml 0001213900-19-003520 3473
2019-02-20 8-K CURRENT REPORT 5.02,5.03,8.01,9.01 0001213900-19-002926 001-38803 19619108 34 343534
2019-02-15 424B4 424B4 0001615774-19-002658 333-227772 19612564 33 1973739
2019-02-15 CT ORDER filename1.pdf 20190215,20190214 9999999997-19-000376 333-227772 19609937 33 92025
2019-02-15 3 FORM 3 0001615774-19-002599 9866
2019-02-15 3 FORM 3 0001615774-19-002597 10508
2019-02-15 3 FORM 3 0001615774-19-002595 11685
2019-02-15 3 FORM 3 0001615774-19-002593 11499
2019-02-15 3 FORM 3 0001615774-19-002591 12432
2019-02-14 EFFECT xslEFFECTX01/primary_doc.xml S-1,,2019-02-14 16:00:00 9999999995-19-000250 333-227772 19609720 33 1689
2019-02-11 CORRESP filename1.htm 0001615774-19-002263 11093
2019-02-11 CORRESP filename1.htm 0001615774-19-002261 10106
2019-02-11 CORRESP filename1.htm 0001615774-19-002259 5770
2019-02-11 CORRESP filename1.htm 0001615774-19-002257 9695
2019-02-11 S-1/A FORM S-1/A 0001615774-19-002253 333-227772 19586034 33 2172617
2019-02-07 CERT HOTH_8A_Certification.pdf 0001354457-19-000061 001-38803 19573699 34 179325
2019-02-06 CORRESP filename1.htm 0001615774-19-002005 9236
2019-02-06 CORRESP filename1.htm 0001615774-19-002003 8296
2019-02-06 S-1/A S-1/A 0001615774-19-002001 333-227772 19572148 33 2172458
2019-02-06 8-A12B 8-A12B 0001615774-19-001991 001-38803 19571627 34 22747
2019-02-05 S-1/A S-1/A 0001615774-19-001957 333-227772 19568985 33 2298410
2019-02-05 CORRESP filename1.htm 0001615774-19-001958 10078
2019-02-05 UPLOAD filename1.pdf 0000000000-19-001057 49647
2019-02-04 S-1/A S-1/A 0001615774-19-001852 333-227772 19565364 33 2169050
2019-02-01 S-1/A S-1/A 0001615774-19-001684 333-227772 19560907 33 2169892
2019-02-01 CORRESP filename1.htm 0001615774-19-001685 14142
2019-02-01 UPLOAD filename1.pdf 0000000000-19-000617 50805
2019-01-11 S-1/A FORM S-1/A 0001615774-19-000531 333-227772 19522491 33 2553249
2018-12-14 S-1/A S-1/A 0001615774-18-014482 333-227772 181236412 33 13148808
2018-12-14 CORRESP filename1.htm 0001615774-18-014483 10153
2018-10-26 UPLOAD filename1.pdf 0000000000-18-033579 49741
2018-10-10 S-1 S-1 0001615774-18-010669 333-227772 181116984 33 2053005
2018-10-10 CORRESP filename1.htm 0001615774-18-010671 11441
2018-09-04 UPLOAD filename1.pdf 0000000000-18-027308 49814
2018-08-14 DRS/A filename1.htm 0001615774-18-007947 377-02129 181014013 33 1792672
2018-08-13 DRSLTR filename1.htm 0001615774-18-007949 57923
2018-07-18 UPLOAD filename1.pdf 0000000000-18-022089 60788
2018-06-21 DRS filename1.htm 0001615774-18-005553 377-02129 18910892 33 12404938
2017-11-07 D xslFormDX01/primary_doc.xml 06b 0001213900-17-011517 021-298256 171184109 33 9673
2017-07-14 D xslFormDX01/primary_doc.xml 06b 0001213900-17-007563 021-290781 17965214 33 7859

Latest XBRL company facts

One latest value per concept from companyfacts (395 concepts). Full history stays in the JSON.

TaxonomyTagLabelUnitValueStartEndFYFPFormFiledAccn
dei EntityCommonStockSharesOutstanding Entity Common Stock, Shares Outstanding shares 24.90M 2026-11-12 2026 Q3 10-Q 2026-11-13 0001213900-26-119676
dei EntityPublicFloat Entity Public Float USD 15.40M 2025-06-30 2025 FY 10-K 2026-03-27 0001213900-26-035625
ecd PeoActuallyPaidCompAmt PeoActuallyPaidCompAmt USD 1.93M 2025-01-01 2025-12-31 DEF 14A 2026-10-23 0001213900-26-112099
ecd PeoTotalCompAmt PeoTotalCompAmt USD 1.93M 2025-01-01 2025-12-31 DEF 14A 2026-10-23 0001213900-26-112099
ecd TotalShareholderRtnAmt TotalShareholderRtnAmt USD 1.67 2025-01-01 2025-12-31 DEF 14A 2026-10-23 0001213900-26-112099
us-gaap AccountsPayableCurrent Accounts Payable, Current USD 695,785 2026-09-30 2026 Q3 10-Q 2026-11-13 0001213900-26-119676
us-gaap AccountsPayableOtherCurrentAndNoncurrent Accounts Payable, Other USD 260,000 2023-12-31 2024 FY 10-K 2025-03-28 0001013762-25-004108
us-gaap AccountsReceivableNetCurrent Accounts Receivable, after Allowance for Credit Loss, Current USD 4,523 2026-09-30 2026 Q3 10-Q 2026-11-13 0001213900-26-119676
us-gaap AccruedLiabilitiesCurrent Accrued Liabilities, Current USD 540,779 2026-09-30 2026 Q3 10-Q 2026-11-13 0001213900-26-119676
us-gaap AccumulatedOtherComprehensiveIncomeLossNetOfTax Accumulated Other Comprehensive Income (Loss), Net of Tax USD 9,604 2026-09-30 2026 Q3 10-Q 2026-11-13 0001213900-26-119676
us-gaap AdditionalPaidInCapital Additional Paid in Capital USD 89.50M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001213900-26-119676
us-gaap AdjustmentForAmortization Amortization USD -8.19M 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-28 0001013762-25-004108
us-gaap AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue APIC, Share-based Payment Arrangement, Increase for Cost Recognition USD 625,485 2026-04-01 2026-06-30 2026 Q3 10-Q 2026-11-13 0001213900-26-119676
us-gaap AdjustmentsToAdditionalPaidInCapitalWarrantIssued Adjustments to Additional Paid in Capital, Warrant Issued USD 333,150 2025-04-01 2025-06-30 2026 Q3 10-Q 2026-11-13 0001213900-26-119676
us-gaap AllocatedShareBasedCompensationExpense Share-based Payment Arrangement, Expense USD 800,216 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001213900-26-119676
us-gaap AllowanceForDoubtfulAccountsReceivable Accounts Receivable, Allowance for Credit Loss USD 387,400 2022-09-30 2022 Q3 10-Q 2022-11-10 0001213900-22-071279
us-gaap AmortizationOfDebtDiscountPremium Amortization of Debt Discount (Premium) USD 144,000 2017-05-02 2017-05-31 2018 FY 10-K 2019-04-01 0001213900-19-005307
us-gaap AmortizationOfFinancingCosts Amortization of Debt Issuance Costs USD 16,533 2021-01-01 2021-09-30 2021 Q3 10-Q 2021-11-10 0001213900-21-058131
us-gaap AmortizationOfIntangibleAssets Amortization of Intangible Assets USD 208,846 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001213900-26-119676
us-gaap AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount shares 6.99M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001213900-26-119676
us-gaap AssetImpairmentCharges Asset Impairment Charges USD 400,000 2023-01-01 2023-12-31 2023 FY 10-K 2024-03-28 0001213900-24-027213
us-gaap Assets Assets USD 8.66M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001213900-26-119676
us-gaap AssetsCurrent Assets, Current USD 6.86M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001213900-26-119676
us-gaap AssetsNoncurrent Assets, Noncurrent USD 1.80M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001213900-26-119676
us-gaap BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets USD 804,885 2026-09-30 2026 Q3 10-Q 2026-11-13 0001213900-26-119676
us-gaap BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Other USD 722 2026-09-30 2026 Q3 10-Q 2026-11-13 0001213900-26-119676
us-gaap BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Receivables USD 4,523 2026-09-30 2026 Q3 10-Q 2026-11-13 0001213900-26-119676
us-gaap BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Accounts Payable USD 12,727 2026-09-30 2026 Q3 10-Q 2026-11-13 0001213900-26-119676
us-gaap BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Other than Goodwill USD 208,846 2026-09-30 2026 Q3 10-Q 2026-11-13 0001213900-26-119676
us-gaap BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities USD 62,203 2026-09-30 2026 Q3 10-Q 2026-11-13 0001213900-26-119676
us-gaap BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net USD 742,682 2026-09-30 2026 Q3 10-Q 2026-11-13 0001213900-26-119676
us-gaap Cash Cash USD 3.20M 2019-09-30 2019 Q3 10-Q 2019-11-12 0001213900-19-022971
us-gaap CashAndCashEquivalentsAtCarryingValue Cash and Cash Equivalents, at Carrying Value USD 6.02M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001213900-26-119676
us-gaap CashAndCashEquivalentsPeriodIncreaseDecrease Cash and Cash Equivalents, Period Increase (Decrease) USD 2.66M 2020-01-01 2020-03-31 2020 Q1 10-Q 2020-05-13 0001213900-20-012014
us-gaap CashCashEquivalentsAndShortTermInvestments Cash, Cash Equivalents, and Short-term Investments USD 1.30M 2017-12-31 2018 FY 10-K 2019-04-01 0001213900-19-005307
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents USD 6.02M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001213900-26-119676
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect USD -230,185 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001213900-26-119676
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect USD 6.62M 2023-01-01 2023-03-31 2023 Q1 10-Q 2023-05-15 0001213900-23-039789
us-gaap CashEquivalentsAtCarryingValue Cash Equivalents, at Carrying Value USD 6.02M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001213900-26-119676
us-gaap CashFDICInsuredAmount Cash, FDIC Insured Amount USD 250,000 2026-09-30 2026 Q3 10-Q 2026-11-13 0001213900-26-119676
us-gaap CashHeldInForeignCurrency CashHeldInForeignCurrency USD 87,000 2026-09-30 2026 Q3 10-Q 2026-11-13 0001213900-26-119676
us-gaap CashUninsuredAmount Cash, Uninsured Amount USD 11.17M 2023-09-30 2023 Q3 10-Q 2023-11-13 0001213900-23-086133
us-gaap ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1 Change in Unrealized Gain (Loss) on Hedged Item in Fair Value Hedge USD 27,000 2022-10-01 2022-12-31 2023 Q3 10-Q 2023-11-13 0001213900-23-086133
us-gaap ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 Class of Warrant or Right, Exercise Price of Warrants or Rights USD/shares 0.85 2026-04-02 2026 Q3 10-Q 2026-11-13 0001213900-26-119676
us-gaap ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights Class of Warrant or Right, Number of Securities Called by Warrants or Rights shares 300,000 2025-06-04 2025 FY 10-K 2026-03-27 0001213900-26-035625
us-gaap ClassOfWarrantOrRightOutstanding Class of Warrant or Right, Outstanding shares 142,857 2026-04-01 2026 Q2 10-Q 2026-08-14 0001213900-26-090048
us-gaap CollateralizedAgreements Collateralized Agreements USD 4.82M 2025-11-13 2026 Q1 10-Q 2026-05-15 0001213900-26-057726
us-gaap CommonStockCapitalSharesReservedForFutureIssuance Common Stock, Capital Shares Reserved for Future Issuance shares 3.09M 2025-05-09 2025 FY 10-K 2026-03-27 0001213900-26-035625
us-gaap CommonStockParOrStatedValuePerShare Common Stock, Par or Stated Value Per Share USD/shares 0 2026-09-30 2026 Q3 10-Q 2026-11-13 0001213900-26-119676
us-gaap CommonStockSharesAuthorized Common Stock, Shares Authorized shares 50.00M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001213900-26-119676
us-gaap CommonStockSharesIssued Common Stock, Shares, Issued shares 24.90M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001213900-26-119676
us-gaap CommonStockSharesOutstanding Common Stock, Shares, Outstanding shares 24.90M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001213900-26-119676
us-gaap CommonStockValue Common Stock, Value, Issued USD 2,490 2026-09-30 2026 Q3 10-Q 2026-11-13 0001213900-26-119676
us-gaap CommonUnitIssued Common Unit, Issued shares 549,275 2023-09-13 2023 Q3 10-Q 2023-11-13 0001213900-23-086133
us-gaap CompensationExpenseExcludingCostOfGoodAndServiceSold Compensation Expense, Excluding Cost of Good and Service Sold USD 1.38M 2023-01-01 2023-09-30 2024 Q3 10-Q 2024-11-12 0001213900-24-096778
us-gaap ComprehensiveIncomeNetOfTax Comprehensive Income (Loss), Net of Tax, Attributable to Parent USD -9.21M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001213900-26-119676
us-gaap ConcentrationRiskCreditRiskFinancialInstrumentMaximumExposure Concentration Risk, Credit Risk, Financial Instrument, Maximum Exposure USD 250,000 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-31 0001213900-23-025455
us-gaap ConvertibleDebt Convertible Debt USD 1.00B 2024-03-31 2024 Q1 10-Q 2024-05-14 0001213900-24-042906
us-gaap ConvertibleNotesPayable Convertible Notes Payable USD 50,000 2020-09-10 2023 FY 10-K 2024-03-28 0001213900-24-027213
us-gaap CostsAndExpenses Costs and Expenses USD 29,000 2023-01-01 2023-12-31 2023 FY 10-K 2024-03-28 0001213900-24-027213
us-gaap CryptoAssetAddition CryptoAssetAddition USD 300,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-27 0001213900-26-035625
us-gaap CryptoAssetCost CryptoAssetCost USD 300,000 2025-12-31 2026 Q3 10-Q 2026-11-13 0001213900-26-119676
us-gaap CryptoAssetFairValueCurrent CryptoAssetFairValueCurrent USD 191,367 2025-12-31 2026 Q3 10-Q 2026-11-13 0001213900-26-119676
us-gaap CryptoAssetFairValueNoncurrent CryptoAssetFairValueNoncurrent USD 274,695 2025-09-30 2025 Q3 10-Q 2025-11-12 0001213900-25-109220
us-gaap CryptoAssetRealizedAndUnrealizedLossOperatingAndNonoperating CryptoAssetRealizedAndUnrealizedLossOperatingAndNonoperating USD 44,165 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001213900-26-119676
us-gaap CryptoAssetRealizedLossOperating CryptoAssetRealizedLossOperating USD 44,165 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001213900-26-119676
us-gaap CryptoAssetSale CryptoAssetSale USD 147,202 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001213900-26-119676
us-gaap CryptoAssetUnrealizedGainLossNonoperating CryptoAssetUnrealizedGainLossNonoperating USD -147,202 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-14 0001213900-26-090048
us-gaap CryptoAssetUnrealizedLossOperating CryptoAssetUnrealizedLossOperating USD 108,633 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-27 0001213900-26-035625
us-gaap CumulativeTranslationAdjustmentNetOfTaxPeriodIncreaseDecrease Cumulative Translation Adjustment, Net of Tax, Period Increase (Decrease) USD -1,737 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001213900-26-119676
us-gaap CurrentForeignTaxExpenseBenefit Current Foreign Tax Expense (Benefit) USD -548,660 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-30 0001213900-22-015909
us-gaap CurrentIncomeTaxExpenseBenefit Current Income Tax Expense (Benefit) USD -548,660 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-30 0001213900-22-015909
us-gaap DebtInstrumentFaceAmount Debt Instrument, Face Amount USD 150,000 2023-12-31 2024 FY 10-K 2025-03-28 0001013762-25-004108
us-gaap DeferredCompensationArrangementWithIndividualAllocatedShareBasedCompensationExpense Deferred Compensation Arrangement with Individual, Allocated Share-based Compensation Expense USD 1.10M 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-30 0001213900-22-015909
us-gaap DeferredCompensationCashBasedArrangementsLiabilityCurrent Deferred Compensation Cash-based Arrangements, Liability, Current USD 30,000 2019-12-31 2019 FY 10-K 2020-03-02 0001213900-20-005186
us-gaap DeferredFederalIncomeTaxExpenseBenefit Deferred Federal Income Tax Expense (Benefit) USD 1.49M 2020-01-01 2020-12-31 2020 FY 10-K 2021-03-16 0001213900-21-015764
us-gaap DeferredFederalStateAndLocalTaxExpenseBenefit Deferred Federal, State and Local, Tax Expense (Benefit) USD 1.50M 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-30 0001213900-22-015909
us-gaap DeferredIncomeTaxExpenseBenefit Deferred Income Tax Expense (Benefit) USD 1.49M 2020-01-01 2020-12-31 2020 FY 10-K 2021-03-16 0001213900-21-015764
us-gaap DeferredOfferingCosts Deferred Offering Costs USD 57,171 2025-12-31 2026 Q3 10-Q 2026-11-13 0001213900-26-119676
us-gaap DeferredOtherTaxExpenseBenefit Deferred Other Tax Expense (Benefit) USD 1.50M 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-31 0001213900-23-025455
us-gaap DeferredStateAndLocalIncomeTaxExpenseBenefit Deferred State and Local Income Tax Expense (Benefit) USD 2,825 2018-01-01 2018-12-31 2019 FY 10-K 2020-03-02 0001213900-20-005186
us-gaap DeferredTaxAssetsCapitalLossCarryforwards Deferred Tax Assets, Capital Loss Carryforwards USD 998,295 2025-12-31 2025 FY 10-K 2026-03-27 0001213900-26-035625
us-gaap DeferredTaxAssetsGross Deferred Tax Assets, Gross USD 21.26M 2025-12-31 2025 FY 10-K 2026-03-27 0001213900-26-035625
us-gaap DeferredTaxAssetsInProcessResearchAndDevelopment Deferred Tax Assets, in Process Research and Development USD 444,866 2021-12-31 2022 FY 10-K 2023-03-31 0001213900-23-025455
us-gaap DeferredTaxAssetsLiabilitiesNet Deferred Tax Assets, Net USD 4.03M 2020-12-31 2020 FY 10-K 2021-03-16 0001213900-21-015764
us-gaap DeferredTaxAssetsNetCurrent Deferred Tax Assets, Net of Valuation Allowance, Current USD 2.54M 2019-12-31 2019 FY 10-K 2020-03-02 0001213900-20-005186
us-gaap DeferredTaxAssetsOperatingLossCarryforwards Deferred Tax Assets, Operating Loss Carryforwards USD 18.65M 2025-12-31 2025 FY 10-K 2026-03-27 0001213900-26-035625
us-gaap DeferredTaxAssetsOperatingLossCarryforwardsDomestic Deferred Tax Assets, Operating Loss Carryforwards, Domestic USD 58.70M 2025-12-31 2025 FY 10-K 2026-03-27 0001213900-26-035625
us-gaap DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal Deferred Tax Assets, Operating Loss Carryforwards, State and Local USD 32.90M 2022-12-31 2022 FY 10-K 2023-03-31 0001213900-23-025455
us-gaap DeferredTaxAssetsOther Deferred Tax Assets, Other USD 72 2021-12-31 2022 FY 10-K 2023-03-31 0001213900-23-025455
us-gaap DeferredTaxAssetsTaxCreditCarryforwards Deferred Tax Assets, Tax Credit Carryforwards USD 15.90M 2020-12-31 2020 FY 10-K 2021-03-16 0001213900-21-015764
us-gaap DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeBenefits Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Employee Benefits USD 3.00M 2024-12-31 2024 FY 10-K 2025-03-28 0001013762-25-004108
us-gaap DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost USD 733,745 2025-12-31 2025 FY 10-K 2026-03-27 0001213900-26-035625
us-gaap DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals USD 215,152 2022-12-31 2022 FY 10-K 2023-03-31 0001213900-23-025455
us-gaap DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsLegalSettlements Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Legal Settlements USD 254,947 2024-12-31 2024 FY 10-K 2025-03-28 0001013762-25-004108
us-gaap DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Other USD 273,254 2025-12-31 2025 FY 10-K 2026-03-27 0001213900-26-035625
us-gaap DeferredTaxAssetsValuationAllowance Deferred Tax Assets, Valuation Allowance USD 21.26M 2025-12-31 2025 FY 10-K 2026-03-27 0001213900-26-035625
us-gaap DeferredTaxLiabilitiesDeferredExpenseCapitalizedResearchAndDevelopmentCosts Deferred Tax Liabilities, Deferred Expense, Capitalized Research and Development Costs USD 1.20M 2022-12-31 2022 FY 10-K 2023-03-31 0001213900-23-025455
us-gaap DepositLiabilitiesAccruedInterest Deposit Liabilities, Accrued Interest USD 50,000 2022-12-31 2022 FY 10-K 2023-03-31 0001213900-23-025455
us-gaap Depreciation Depreciation USD 1,043 2020-01-01 2020-12-31 2021 FY 10-K 2022-03-30 0001213900-22-015909
us-gaap DirectTaxesAndLicensesCosts Cost, Direct Tax and License USD 10,000 2020-01-01 2020-12-31 2020 FY 10-K 2021-03-16 0001213900-21-015764
us-gaap DividendIncomeOperating Dividend Income, Operating USD 13,956 2024-01-01 2024-03-31 2024 Q1 10-Q 2024-05-14 0001213900-24-042906
us-gaap EarningsPerShareBasic Earnings Per Share, Basic USD/shares -0.45 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001213900-26-119676
us-gaap EarningsPerShareBasicAndDiluted Earnings Per Share, Basic and Diluted USD/shares -0.64 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-30 0001213900-22-015909
us-gaap EarningsPerShareDiluted Earnings Per Share, Diluted USD/shares -0.45 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001213900-26-119676
us-gaap EffectiveIncomeTaxRateContinuingOperations Effective Income Tax Rate Reconciliation, Percent pure 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-27 0001213900-26-035625
us-gaap EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent pure 0.21 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-27 0001213900-26-035625
us-gaap EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent pure -0.194 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-27 0001213900-26-035625
us-gaap EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Percent pure 0 2023-01-01 2023-12-31 2023 FY 10-K 2024-03-28 0001213900-24-027213
us-gaap EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Percent pure 0.001 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-27 0001213900-26-035625
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Percent pure 0 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-28 0001013762-25-004108
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Percent pure 0 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-27 0001213900-26-035625
us-gaap EffectiveIncomeTaxRateReconciliationOtherAdjustments Effective Income Tax Rate Reconciliation, Other Adjustments, Percent pure 0 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-27 0001213900-26-035625
us-gaap EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent Effective Income Tax Rate Reconciliation,Other Reconciling Items, Percent pure 0 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-28 0001013762-25-004108
us-gaap EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes Effective Income Tax Rate Reconciliation, Prior Year Income Taxes, Percent pure -0.005 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-27 0001213900-26-035625
us-gaap EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent pure 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-27 0001213900-26-035625
us-gaap EffectiveIncomeTaxRateReconciliationTaxCredits Effective Income Tax Rate Reconciliation, Tax Credit, Percent pure 0 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-27 0001213900-26-035625
us-gaap EffectOfExchangeRateOnCashAndCashEquivalents Effect of Exchange Rate on Cash and Cash Equivalents USD -30,562 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-30 0001213900-22-015909
us-gaap EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents USD -1,227 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001213900-26-119676
us-gaap EmployeeBenefitsAndShareBasedCompensation Employee Benefits and Share-based Compensation USD 188,502 2023-01-01 2023-09-30 2023 Q3 10-Q 2023-11-13 0001213900-23-086133
us-gaap EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount USD 1,878 2024-03-31 2024 Q1 10-Q 2024-05-14 0001213900-24-042906
us-gaap EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount USD 0 2026-09-30 2026 Q3 10-Q 2026-11-13 0001213900-26-119676
us-gaap EmployeeStockOwnershipPlanESOPCompensationExpense Employee Stock Ownership Plan (ESOP), Compensation Expense USD 700,000 2020-01-01 2020-12-31 2020 FY 10-K 2021-03-16 0001213900-21-015764
us-gaap EquityMethodInvestmentOwnershipPercentage Equity Method Investment, Ownership Percentage pure 0.1 2019-08-16 2020 FY 10-K 2021-03-16 0001213900-21-015764
us-gaap EquityMethodInvestments Equity Method Investments USD 100,000 2026-10-31 2026 Q3 10-Q 2026-11-13 0001213900-26-119676
us-gaap EscrowDeposit Escrow Deposit USD 200,000 2021-03-31 2021 Q1 10-Q 2021-05-13 0001213900-21-026092
us-gaap EscrowDepositDisbursementsRelatedToPropertyAcquisition1 Escrow Deposit Disbursements Related to Property Acquisition USD 80,000 2026-09-21 2026 Q3 10-Q 2026-11-13 0001213900-26-119676
us-gaap ExcessStockSharesIssued Excess Stock, Shares Issued shares 3.75M 2024-03-27 2024 Q1 10-Q 2024-05-14 0001213900-24-042906
us-gaap FairValueAdjustmentOfWarrants Fair Value Adjustment of Warrants USD 333,150 2025-06-04 2025 FY 10-K 2026-03-27 0001213900-26-035625
us-gaap FairValueConcentrationOfRiskInvestmentInFederalHomeLoanBankStock Fair Value, Concentration of Risk, Investment in Federal Home Loan Bank Stock USD 23,000 2022-05-31 2022 Q2 10-Q 2022-08-12 0001213900-22-047409
us-gaap FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisChangeInUnrealizedGainLoss Fair Value, Net Derivative Asset (Liability), Recurring Basis, Still Held, Unrealized Gain (Loss) USD -22,600 2022-01-01 2022-09-30 2022 Q3 10-Q 2022-11-10 0001213900-22-071279
us-gaap FairValueOptionChangesInFairValueGainLoss1 Fair Value, Option, Changes in Fair Value, Gain (Loss) USD -581 2024-01-01 2024-06-30 2024 Q2 10-Q 2024-08-09 0001213900-24-067131
us-gaap FederalDepositInsuranceCorporationPremiumExpense Federal Deposit Insurance Corporation Premium Expense USD 250,000 2023-01-01 2023-09-30 2023 Q3 10-Q 2023-11-13 0001213900-23-086133
us-gaap FederalIncomeTaxExpenseBenefitContinuingOperations Federal Income Tax Expense (Benefit), Continuing Operations USD 57.20M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-27 0001213900-26-035625
us-gaap FederalStateAndLocalIncomeTaxExpenseBenefitContinuingOperations FederalStateAndLocalIncomeTaxExpenseBenefitContinuingOperations USD 1.50M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-27 0001213900-26-035625
us-gaap FinancingReceivableAccruedInterestModified FinancingReceivableAccruedInterestModified USD 6,000 2022-10-16 2022-10-21 2023 FY 10-K 2024-03-28 0001213900-24-027213
us-gaap FinancingReceivableChangeInPresentValueExpenseReversal Financing Receivable, Change in Present Value, Expense (Reversal) USD 10,000 2019-03-01 2019-03-31 2019 FY 10-K 2020-03-02 0001213900-20-005186
us-gaap FinancingReceivableModificationToTotalFinancingReceivablesExcludingAccruedInterestPercent FinancingReceivableModificationToTotalFinancingReceivablesExcludingAccruedInterestPercent pure 0.06 2022-09-04 2022-09-10 2023 FY 10-K 2024-03-28 0001213900-24-027213
us-gaap FinancingReceivablePurchasedWithCreditDeteriorationAmountAtPurchasePrice Financing Receivable, Purchased with Credit Deterioration, Amount at Purchase Price USD 15.00M 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-31 0001213900-23-025455
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive Finite-Lived Intangible Asset, Expected Amortization, after Year Five USD 120,341 2026-09-30 2026 Q3 10-Q 2026-11-13 0001213900-26-119676
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths Finite-Lived Intangible Asset, Expected Amortization, Year One USD 17,701 2026-09-30 2026 Q3 10-Q 2026-11-13 0001213900-26-119676
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseYearFive Finite-Lived Intangible Asset, Expected Amortization, Year Five USD 17,701 2026-09-30 2026 Q3 10-Q 2026-11-13 0001213900-26-119676
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseYearFour Finite-Lived Intangible Asset, Expected Amortization, Year Four USD 17,701 2026-09-30 2026 Q3 10-Q 2026-11-13 0001213900-26-119676
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseYearThree Finite-Lived Intangible Asset, Expected Amortization, Year Three USD 17,701 2026-09-30 2026 Q3 10-Q 2026-11-13 0001213900-26-119676
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo Finite-Lived Intangible Asset, Expected Amortization, Year Two USD 17,701 2026-09-30 2026 Q3 10-Q 2026-11-13 0001213900-26-119676
us-gaap FiniteLivedIntangibleAssetsGross Finite-Lived Intangible Assets, Gross USD 208,846 2026-09-30 2026 Q3 10-Q 2026-11-13 0001213900-26-119676
us-gaap FiniteLivedIntangibleAssetsNet Finite-Lived Intangible Assets, Net USD 208,846 2026-09-30 2026 Q3 10-Q 2026-11-13 0001213900-26-119676
us-gaap FiniteLivedPatentsGross Finite-Lived Patents, Gross USD 15,000 2020-12-31 2020 FY 10-K 2021-03-16 0001213900-21-015764
us-gaap ForeignCurrencyTransactionGainLossBeforeTax Foreign Currency Transaction Gain (Loss), before Tax USD -275 2019-01-01 2019-12-31 2019 FY 10-K 2020-03-02 0001213900-20-005186
us-gaap ForeignCurrencyTransactionGainLossUnrealized Foreign Currency Transaction Gain (Loss), Unrealized USD -59,583 2021-01-01 2021-12-31 2022 FY 10-K 2023-03-31 0001213900-23-025455
us-gaap GainLossOnInvestments Gain (Loss) on Investments USD -567,692 2022-01-01 2022-12-31 2023 FY 10-K 2024-03-28 0001213900-24-027213
us-gaap GainLossOnTerminationOfLease Gain (Loss) on Termination of Lease USD 1,026 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001213900-26-119676
us-gaap GeneralAndAdministrativeExpense General and Administrative Expense USD 4.41M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001213900-26-119676
us-gaap Goodwill Goodwill USD 590,794 2026-09-30 2026 Q3 10-Q 2026-11-13 0001213900-26-119676
us-gaap GoodwillGross Goodwill, Gross USD 590,794 2026-09-30 2026 Q3 10-Q 2026-11-13 0001213900-26-119676
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic Income (Loss) from Continuing Operations before Income Taxes, Domestic USD -12.40M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-27 0001213900-26-035625
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest USD -9.21M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001213900-26-119676
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign Income (Loss) from Continuing Operations before Income Taxes, Foreign USD -67,889 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-27 0001213900-26-035625
us-gaap IncomeLossFromEquityMethodInvestments Income (Loss) from Equity Method Investments USD -377,000 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-31 0001213900-23-025455
us-gaap IncomeTaxReceivable Income Taxes Receivable USD 0 2021-12-31 2021 FY 10-K 2022-03-30 0001213900-22-015909
us-gaap IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount USD -2.41M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-27 0001213900-26-035625
us-gaap IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount USD 2.62M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-27 0001213900-26-035625
us-gaap IncomeTaxReconciliationNondeductibleExpenseResearchAndDevelopment Effective Income Tax Rate Reconciliation, Nondeductible Expense, Research and Development, Amount USD 400,000 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-30 0001213900-22-015909
us-gaap IncomeTaxReconciliationStateAndLocalIncomeTaxes Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-27 0001213900-26-035625
us-gaap IncomeTaxReconciliationTaxCredits Effective Income Tax Rate Reconciliation, Tax Credit, Amount USD 200,000 2023-01-01 2023-12-31 2025 FY 10-K 2026-03-27 0001213900-26-035625
us-gaap IncomeTaxReconciliationTaxCreditsOther Effective Income Tax Rate Reconciliation, Tax Credit, Other, Amount USD 47,000 2023-01-01 2023-12-31 2025 FY 10-K 2026-03-27 0001213900-26-035625
us-gaap IncomeTaxReconciliationTaxCreditsResearch Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount USD 200,000 2023-01-01 2023-12-31 2025 FY 10-K 2026-03-27 0001213900-26-035625
us-gaap IncomeTaxReconciliationTaxSettlementsForeign Effective Income Tax Rate Reconciliation, Tax Settlement, Foreign, Amount USD 6,796 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-27 0001213900-26-035625
us-gaap IncreaseDecreaseInAccountsPayable Increase (Decrease) in Accounts Payable USD -39,305 2024-01-01 2024-03-31 2024 Q1 10-Q 2024-05-14 0001213900-24-042906
us-gaap IncreaseDecreaseInAccountsPayableAndAccruedLiabilities Increase (Decrease) in Accounts Payable and Accrued Liabilities USD -272,636 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001213900-26-119676
us-gaap IncreaseDecreaseInAccruedLiabilities Increase (Decrease) in Accrued Liabilities USD -1,542 2018-01-01 2018-12-31 2019 FY 10-K 2020-03-02 0001213900-20-005186
us-gaap IncreaseDecreaseInIntangibleAssetsCurrent Increase (Decrease) in Intangible Assets, Current USD 799,640 2026-09-21 2026 Q3 10-Q 2026-11-13 0001213900-26-119676
us-gaap IncreaseDecreaseInOtherAccruedLiabilities Increase (Decrease) in Other Accrued Liabilities USD 27,127 2019-01-01 2019-06-30 2020 Q2 10-Q 2020-08-13 0001213900-20-021878
us-gaap IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets Increase (Decrease) in Prepaid Expense and Other Assets USD 155,221 2025-01-01 2025-06-30 2025 Q2 10-Q 2025-08-12 0001213900-25-074968
us-gaap IncreaseDecreaseInPrepaidExpense Increase (Decrease) in Prepaid Expense USD 318,823 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001213900-26-119676
us-gaap InsuranceCommissionsAndFees Insurance Commissions and Fees USD 28,000 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-31 0001213900-23-025455
us-gaap IntangibleAssetsNetExcludingGoodwill Intangible Assets, Net (Excluding Goodwill) USD 208,846 2026-09-30 2026 Q3 10-Q 2026-11-13 0001213900-26-119676
us-gaap InterestExpense Interest Expense USD 144,000 2017-05-16 2017-12-31 2018 FY 10-K 2019-04-01 0001213900-19-005307
us-gaap InterestIncomeFederalFundsSold Interest Income, Federal Funds Sold USD 250,000 2024-01-01 2024-03-31 2024 Q1 10-Q 2024-05-14 0001213900-24-042906
us-gaap InterestIncomeOperating Interest Income, Operating USD 8 2020-01-01 2020-12-31 2021 FY 10-K 2022-03-30 0001213900-22-015909
us-gaap InterestIncomeOther Interest Income, Other USD 28,113 2023-01-01 2023-03-31 2023 Q1 10-Q 2023-05-15 0001213900-23-039789
us-gaap InterestIncomeSecuritiesTaxable Interest Income, Securities, Operating, Taxable USD 65.80M 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-31 0001213900-23-025455
us-gaap InterestPaidNet Interest Paid, Excluding Capitalized Interest, Operating Activities USD 144,000 2017-05-16 2017-12-31 2018 FY 10-K 2019-04-01 0001213900-19-005307
us-gaap InvestmentIncomeDividend Investment Income, Dividend USD 149 2026-01-01 2026-03-31 2026 Q1 10-Q 2026-05-15 0001213900-26-057726
us-gaap InvestmentIncomeInterest Investment Income, Interest USD 448 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001213900-26-119676
us-gaap InvestmentIncomeInvestmentExpense Investment Income, Investment Expense USD 33,000 2023-01-01 2023-09-30 2023 Q3 10-Q 2023-11-13 0001213900-23-086133
us-gaap InvestmentInterestRate Investment Interest Rate pure 0.06 2022-09-10 2022 Q3 10-Q 2022-11-10 0001213900-22-071279
us-gaap InvestmentOwnedAtFairValue Investment Owned, at Fair Value USD 33,000 2023-03-31 2023 Q1 10-Q 2023-05-15 0001213900-23-039789
us-gaap InvestmentOwnedBalancePrincipalAmount Investment Owned, Balance, Principal Amount USD 3,740 2025-09-23 2026 Q3 10-Q 2026-11-13 0001213900-26-119676
us-gaap InvestmentOwnedBalanceShares Investment Owned, Balance, Shares shares 3,740 2025-09-23 2025 FY 10-K 2026-03-27 0001213900-26-035625
us-gaap InvestmentsFairValueDisclosure Investments, Fair Value Disclosure USD 33,000 2023-09-30 2023 Q3 10-Q 2023-11-13 0001213900-23-086133
us-gaap InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures Investments in and Advance to Affiliates, Subsidiaries, Associates, and Joint Ventures USD 36,819 2026-09-30 2026 Q3 10-Q 2026-11-13 0001213900-26-119676
us-gaap InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVenturesFairValueDisclosure Investments in Affiliates, Subsidiaries, Associates, and Joint Ventures, Fair Value Disclosure USD 36,819 2024-12-31 2024 FY 10-K 2025-03-28 0001013762-25-004108
us-gaap LeaseAndRentalExpense Operating Leases, Rent Expense USD 2,732 2025-03-01 2024 FY 10-K 2025-03-28 0001013762-25-004108
us-gaap LeaseCost Lease, Cost USD 20,662 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001213900-26-119676
us-gaap LegalFees Legal Fees USD 30,633 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001213900-26-119676
us-gaap LesseeOperatingLeaseLiabilityPaymentsDue Lessee, Operating Lease, Liability, to be Paid USD 5,750 2025-12-31 2025 FY 10-K 2026-03-27 0001213900-26-035625
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths Lessee, Operating Lease, Liability, to be Paid, Year One USD 5,750 2025-12-31 2025 FY 10-K 2026-03-27 0001213900-26-035625
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearTwo Lessee, Operating Lease, Liability, to be Paid, Year Two USD 2,732 2024-12-31 2024 FY 10-K 2025-03-28 0001013762-25-004108
us-gaap LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year USD 8,196 2025-09-30 2025 Q3 10-Q 2025-11-12 0001213900-25-109220
us-gaap LesseeOperatingLeaseLiabilityUndiscountedExcessAmount Lessee, Operating Lease, Liability, Undiscounted Excess Amount USD 72 2025-12-31 2025 FY 10-K 2026-03-27 0001213900-26-035625
us-gaap Liabilities Liabilities USD 1.24M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001213900-26-119676
us-gaap LiabilitiesAndStockholdersEquity Liabilities and Equity USD 8.66M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001213900-26-119676
us-gaap LiabilitiesCurrent Liabilities, Current USD 1.24M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001213900-26-119676
us-gaap LiabilitiesFairValueAdjustment Liabilities, Fair Value Adjustment USD -581 2024-01-01 2024-03-31 2024 Q1 10-Q 2024-05-14 0001213900-24-042906
us-gaap LiabilitiesNoncurrent Liabilities, Noncurrent USD 2,709 2024-12-31 2025 FY 10-K 2026-03-27 0001213900-26-035625
us-gaap MarketableSecurities Marketable Securities USD 24,567 2023-09-30 2023 Q3 10-Q 2023-11-13 0001213900-23-086133
us-gaap MarketableSecuritiesCurrent Marketable Securities, Current USD 209,320 2022-12-31 2023 FY 10-K 2024-03-28 0001213900-24-027213
us-gaap MarketableSecuritiesGainLoss Marketable Securities, Gain (Loss) USD -132,063 2022-01-01 2022-09-30 2023 Q3 10-Q 2023-11-13 0001213900-23-086133
us-gaap MarketableSecuritiesRealizedGainLoss Marketable Securities, Realized Gain (Loss) USD -567,692 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-31 0001213900-23-025455
us-gaap MarketableSecuritiesUnrealizedGainLoss Marketable Securities, Unrealized Gain (Loss) USD -209,320 2023-01-01 2023-12-31 2024 FY 10-K 2025-03-28 0001013762-25-004108
us-gaap MarketableSecuritiesUnrealizedGainLossExcludingOtherThanTemporaryImpairments Marketable Securities, Unrealized Gain (Loss), Excluding Other-than-temporary Impairment Loss USD -184,753 2023-01-01 2023-09-30 2023 Q3 10-Q 2023-11-13 0001213900-23-086133
us-gaap NetCashProvidedByUsedInFinancingActivities Net Cash Provided by (Used in) Financing Activities USD 9.42M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001213900-26-119676
us-gaap NetCashProvidedByUsedInInvestingActivities Net Cash Provided by (Used in) Investing Activities USD -845,480 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001213900-26-119676
us-gaap NetCashProvidedByUsedInOperatingActivities Net Cash Provided by (Used in) Operating Activities USD -8.80M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001213900-26-119676
us-gaap NetIncomeLoss Net Income (Loss) Attributable to Parent USD -9.21M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001213900-26-119676
us-gaap NetIncomeLossAvailableToCommonStockholdersBasic Net Income (Loss) Available to Common Stockholders, Basic USD -7.85M 2023-01-01 2023-12-31 2023 FY 10-K 2024-03-28 0001213900-24-027213
us-gaap NonoperatingIncomeExpense Nonoperating Income (Expense) USD -193,717 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001213900-26-119676
us-gaap NotesPayable Notes Payable USD 450,000 2017-05-31 2018 FY 10-K 2019-04-01 0001213900-19-005307
us-gaap NotesReceivableRelatedPartiesCurrent Notes Receivable, Related Parties, Current USD 50,000 2021-12-31 2022 FY 10-K 2023-03-31 0001213900-23-025455
us-gaap NumberOfOperatingSegments Number of Operating Segments Segment 1 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001213900-26-119676
us-gaap OperatingExpenses Operating Expenses USD 9.01M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001213900-26-119676
us-gaap OperatingIncomeLoss Operating Income (Loss) USD -9.01M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001213900-26-119676
us-gaap OperatingLeaseCost Operating Lease, Cost USD 4,652 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001213900-26-119676
us-gaap OperatingLeaseLiability Operating Lease, Liability USD 5,678 2025-12-31 2026 Q3 10-Q 2026-11-13 0001213900-26-119676
us-gaap OperatingLeaseLiabilityCurrent Operating Lease, Liability, Current USD 5,678 2025-12-31 2026 Q3 10-Q 2026-11-13 0001213900-26-119676
us-gaap OperatingLeaseLiabilityNoncurrent Operating Lease, Liability, Noncurrent USD 2,709 2024-12-31 2025 FY 10-K 2026-03-27 0001213900-26-035625
us-gaap OperatingLeasePayments Operating Lease, Payments USD 5,678 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001213900-26-119676
us-gaap OperatingLeaseRightOfUseAsset Operating Lease, Right-of-Use Asset USD 4,652 2025-12-31 2026 Q3 10-Q 2026-11-13 0001213900-26-119676
us-gaap OperatingLeaseRightOfUseAssetAmortizationExpense Operating Lease, Right-of-Use Asset, Amortization Expense USD 49,875 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001213900-26-119676
us-gaap OperatingLossCarryforwards Operating Loss Carryforwards USD 500,000 2023-12-31 2023 FY 10-K 2024-03-28 0001213900-24-027213
us-gaap OtherAdditionalCapital Other Additional Capital USD 500,000 2017-05-31 2018 FY 10-K 2019-04-01 0001213900-19-005307
us-gaap OtherAssetsNoncurrent Other Assets, Noncurrent USD 85,041 2024-03-31 2024 Q1 10-Q 2024-05-14 0001213900-24-042906
us-gaap OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, before Tax USD -275 2019-01-01 2019-12-31 2020 FY 10-K 2021-03-16 0001213900-21-015764
us-gaap OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax USD -1,227 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001213900-26-119676
us-gaap OtherDeferredCostsNet Other Deferred Costs, Net USD 0 2020-12-31 2020 FY 10-K 2021-03-16 0001213900-21-015764
us-gaap OtherExpenses Other Expenses USD 388,121 2026-04-01 2026 Q3 10-Q 2026-11-13 0001213900-26-119676
us-gaap OtherGeneralAndAdministrativeExpense Other General and Administrative Expense USD 440,152 2023-01-01 2023-09-30 2024 Q3 10-Q 2024-11-12 0001213900-24-096778
us-gaap OtherInvestments Other Investments USD 36,819 2024-03-31 2024 Q1 10-Q 2024-05-14 0001213900-24-042906
us-gaap OtherNoncashExpense Other Noncash Expense USD 1,026 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-27 0001213900-26-035625
us-gaap OtherNonoperatingIncome Other Nonoperating Income USD 298 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-14 0001213900-26-090048
us-gaap OtherNonoperatingIncomeExpense Other Nonoperating Income (Expense) USD 448 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001213900-26-119676
us-gaap OtherPrepaidExpenseCurrent Other Prepaid Expense, Current USD 109,725 2026-09-30 2026 Q3 10-Q 2026-11-13 0001213900-26-119676
us-gaap OtherResearchAndDevelopmentExpense Other Research and Development Expense USD 280,400 2024-01-01 2024-09-30 2024 FY 10-K 2025-03-28 0001013762-25-004108
us-gaap OtherSellingGeneralAndAdministrativeExpense Other Selling, General and Administrative Expense USD 440,152 2023-01-01 2023-09-30 2023 Q3 10-Q 2023-11-13 0001213900-23-086133
us-gaap PartnersCapitalAccountPublicSaleOfUnitsNetOfOfferingCosts Partners' Capital Account, Public Sale of Units Net of Offering Costs USD 1.20M 2018-01-01 2018-12-31 2019 FY 10-K 2020-03-02 0001213900-20-005186
us-gaap PartnersCapitalAccountUnitsSoldInPublicOffering Partners' Capital Account, Units, Sold in Public Offering shares 329,412 2022-04-01 2022-04-14 2022 Q3 10-Q 2022-11-10 0001213900-22-071279
us-gaap PaymentForAcquisitionCryptoAsset PaymentForAcquisitionCryptoAsset USD 300,000 2025-01-01 2025-09-30 2026 Q3 10-Q 2026-11-13 0001213900-26-119676
us-gaap PaymentsForRent Payments for Rent USD 2,732 2025-03-01 2025-12-31 2026 Q3 10-Q 2026-11-13 0001213900-26-119676
us-gaap PaymentsForRepurchaseOfPreferredStockAndPreferenceStock Payments for Repurchase of Preferred Stock and Preference Stock USD 10 2022-01-01 2022-12-31 2023 FY 10-K 2024-03-28 0001213900-24-027213
us-gaap PaymentsOfStockIssuanceCosts Payments of Stock Issuance Costs USD 57,171 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-27 0001213900-26-035625
us-gaap PaymentsRelatedToTaxWithholdingForShareBasedCompensation Payment, Tax Withholding, Share-based Payment Arrangement USD 376,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-27 0001213900-26-035625
us-gaap PaymentsToAcquireBusinessesGross Payments to Acquire Businesses, Gross USD 742,682 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001213900-26-119676
us-gaap PaymentsToAcquireEquityMethodInvestments Payments to Acquire Equity Method Investments USD 250,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001213900-26-119676
us-gaap PaymentsToAcquireInProcessResearchAndDevelopment Payments to Acquire in Process Research and Development USD 74,000 2022-01-01 2022-12-31 2023 FY 10-K 2024-03-28 0001213900-24-027213
us-gaap PaymentsToAcquireMarketableSecurities Payments to Acquire Marketable Securities USD 800,000 2019-01-01 2019-12-31 2019 FY 10-K 2020-03-02 0001213900-20-005186
us-gaap PaymentsToAcquirePropertyPlantAndEquipment Payments to Acquire Property, Plant, and Equipment USD 3,680 2017-05-16 2017-12-31 2018 FY 10-K 2019-04-01 0001213900-19-005307
us-gaap PaymentsToMinorityShareholders Payments to Noncontrolling Interests USD 3.00M 2020-03-01 2020-03-27 2023 Q1 10-Q 2023-05-15 0001213900-23-039789
us-gaap PreferredStockDividendsAndOtherAdjustments Preferred Stock Dividends and Other Adjustments USD -990 2022-01-01 2022-12-31 2023 FY 10-K 2024-03-28 0001213900-24-027213
us-gaap PreferredStockParOrStatedValuePerShare Preferred Stock, Par or Stated Value Per Share USD/shares 0 2026-09-30 2026 Q3 10-Q 2026-11-13 0001213900-26-119676
us-gaap PreferredStockSharesAuthorized Preferred Stock, Shares Authorized shares 10.00M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001213900-26-119676
us-gaap PreferredStockSharesIssued Preferred Stock, Shares Issued shares 0 2026-09-30 2026 Q3 10-Q 2026-11-13 0001213900-26-119676
us-gaap PreferredStockSharesOutstanding Preferred Stock, Shares Outstanding shares 0 2026-09-30 2026 Q3 10-Q 2026-11-13 0001213900-26-119676
us-gaap PrepaidExpenseAndOtherAssets Prepaid Expense and Other Assets USD 1.80M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001213900-26-119676
us-gaap PrepaidExpenseAndOtherAssetsCurrent Prepaid Expense and Other Assets, Current USD 836,197 2026-09-30 2026 Q3 10-Q 2026-11-13 0001213900-26-119676
us-gaap PrepaidExpenseAndOtherAssetsNoncurrent Prepaid Expense and Other Assets, Noncurrent USD 967,135 2026-09-30 2026 Q3 10-Q 2026-11-13 0001213900-26-119676
us-gaap PrepaidExpenseCurrent Prepaid Expense, Current USD 200,328 2023-09-30 2023 Q3 10-Q 2023-11-13 0001213900-23-086133
us-gaap PrepaidExpenseOtherNoncurrent Prepaid Expense Other, Noncurrent USD 100,000 2026-09-30 2026 Q3 10-Q 2026-11-13 0001213900-26-119676
us-gaap PrepaidInsurance Prepaid Insurance USD 85,815 2026-09-30 2026 Q3 10-Q 2026-11-13 0001213900-26-119676
us-gaap PrepaidRent Prepaid Rent USD 15,120 2024-03-31 2024 Q1 10-Q 2024-05-14 0001213900-24-042906
us-gaap ProceedsFromBankDebt Proceeds from Bank Debt USD 100,000 2024-01-01 2024-03-31 2024 Q1 10-Q 2024-05-14 0001213900-24-042906
us-gaap ProceedsFromDebtNetOfIssuanceCosts Proceeds from Debt, Net of Issuance Costs USD 1.01M 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-31 0001213900-23-025455
us-gaap ProceedsFromDisposalCryptoAsset ProceedsFromDisposalCryptoAsset USD 147,202 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001213900-26-119676
us-gaap ProceedsFromIssuanceInitialPublicOffering Proceeds from Issuance Initial Public Offering USD 1.16M 2019-01-01 2019-12-31 2020 FY 10-K 2021-03-16 0001213900-21-015764
us-gaap ProceedsFromIssuanceOfCommonLimitedPartnersUnits Proceeds from Issuance of Common Limited Partners Units USD 13.77 2018-01-01 2018-12-31 2019 FY 10-K 2020-03-02 0001213900-20-005186
us-gaap ProceedsFromIssuanceOfCommonStock Proceeds from Issuance of Common Stock USD 7.75M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001213900-26-119676
us-gaap ProceedsFromIssuanceOfConvertiblePreferredStock Proceeds from Issuance of Convertible Preferred Stock USD -10 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-31 0001213900-23-025455
us-gaap ProceedsFromIssuanceOfPreferredStockAndPreferenceStock Proceeds from Issuance of Preferred Stock and Preference Stock USD 1,000 2022-01-01 2022-12-31 2023 FY 10-K 2024-03-28 0001213900-24-027213
us-gaap ProceedsFromIssuanceOfPrivatePlacement Proceeds from Issuance of Private Placement USD 701,484 2026-01-01 2026-03-31 2026 Q1 10-Q 2026-05-15 0001213900-26-057726
us-gaap ProceedsFromIssuanceOfWarrants Proceeds from Issuance of Warrants USD 358,745 2021-01-01 2021-03-31 2022 Q1 10-Q 2022-05-12 0001213900-22-025987
us-gaap ProceedsFromIssuanceOrSaleOfEquity Proceeds from Issuance or Sale of Equity USD 15.00M 2023-01-01 2023-01-03 2023 Q3 10-Q 2023-11-13 0001213900-23-086133
us-gaap ProceedsFromLeasePayments Proceeds from Lease Payment, Operating Activity USD 8,196 2024-01-01 2024-03-31 2024 Q1 10-Q 2024-05-14 0001213900-24-042906
us-gaap ProceedsFromLicenseFeesReceived Proceeds from License Fees Received USD 5,000 2020-01-01 2020-12-31 2020 FY 10-K 2021-03-16 0001213900-21-015764
us-gaap ProceedsFromNotesPayable Proceeds from Notes Payable USD 204,000 2017-05-16 2017-12-31 2018 FY 10-K 2019-04-01 0001213900-19-005307
us-gaap ProceedsFromOtherEquity Proceeds from Other Equity USD 13.50M 2021-03-01 2021-03-08 2022 FY 10-K 2023-03-31 0001213900-23-025455
us-gaap ProceedsFromPaymentsForOtherFinancingActivities Proceeds from (Payments for) Other Financing Activities USD 50,000 2022-01-01 2022-12-31 2023 FY 10-K 2024-03-28 0001213900-24-027213
us-gaap ProceedsFromPaymentsForTradingSecurities Proceeds from (Payments for) Trading Securities, Short-term USD -2.56M 2021-01-01 2021-12-31 2022 FY 10-K 2023-03-31 0001213900-23-025455
us-gaap ProceedsFromRepaymentsOfNotesPayable Proceeds from (Repayments of) Notes Payable USD 50,000 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-31 0001213900-23-025455
us-gaap ProceedsFromSaleAndMaturityOfMarketableSecurities Proceeds from Sale and Maturity of Marketable Securities USD 1.24M 2022-01-01 2022-12-31 2023 FY 10-K 2024-03-28 0001213900-24-027213
us-gaap ProceedsFromStockOptionsExercised Proceeds from Stock Options Exercised USD 10,000 2020-01-01 2020-12-31 2020 FY 10-K 2021-03-16 0001213900-21-015764
us-gaap ProceedsFromWarrantExercises Proceeds from Warrant Exercises USD 5.63M 2025-01-01 2025-09-30 2026 Q3 10-Q 2026-11-13 0001213900-26-119676
us-gaap ProfessionalFees Professional Fees USD 174,731 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001213900-26-119676
us-gaap ProfitLoss Net Income (Loss), Including Portion Attributable to Noncontrolling Interest USD -2.57M 2022-01-01 2022-03-31 2022 Q1 10-Q 2022-05-12 0001213900-22-025987
us-gaap PropertyPlantAndEquipmentNet Property, Plant and Equipment, Net USD 1,043 2019-12-31 2020 FY 10-K 2021-03-16 0001213900-21-015764
us-gaap PurchaseOptionsLand Purchase Options, Land USD 250,000 2020-03-27 2023 FY 10-K 2024-03-28 0001213900-24-027213
us-gaap RealizedInvestmentGainsLosses Realized Investment Gains (Losses) USD -567,692 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-31 0001213900-23-025455
us-gaap ReceivablesFairValueDisclosure Receivables, Fair Value Disclosure USD 50,000 2021-12-31 2022 FY 10-K 2023-03-31 0001213900-23-025455
us-gaap RepaymentsOfNotesPayable Repayments of Notes Payable USD 204,000 2017-05-16 2017-12-31 2018 FY 10-K 2019-04-01 0001213900-19-005307
us-gaap ResearchAndDevelopmentExpense Research and Development Expense USD 4.60M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001213900-26-119676
us-gaap RestrictedCash Restricted Cash USD 4.35M 2020-03-31 2021 Q1 10-Q 2021-05-13 0001213900-21-026092
us-gaap RestrictedCashAndCashEquivalents Restricted Cash and Cash Equivalents USD 4.55M 2020-03-31 2021 Q1 10-Q 2021-05-13 0001213900-21-026092
us-gaap RestrictedCashEquivalents Restricted Cash Equivalents USD 200,000 2020-03-31 2021 Q1 10-Q 2021-05-13 0001213900-21-026092
us-gaap RestrictedCashNoncurrent Restricted Cash, Noncurrent USD 200,000 2019-12-31 2020 FY 10-K 2021-03-16 0001213900-21-015764
us-gaap RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings Restricted Stock, Shares Issued Net of Shares for Tax Withholdings shares 300,000 2025-06-04 2025 Q3 10-Q 2025-11-12 0001213900-25-109220
us-gaap RetainedEarningsAccumulatedDeficit Retained Earnings (Accumulated Deficit) USD -82.09M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001213900-26-119676
us-gaap RevenueFromContractWithCustomerIncludingAssessedTax Revenue from Contract with Customer, Including Assessed Tax USD 1.24B 2024-01-01 2024-09-30 2024 Q3 10-Q 2024-11-12 0001213900-24-096778
us-gaap Revenues Revenues USD 35 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001213900-26-119676
us-gaap RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability Right-of-Use Asset Obtained in Exchange for Operating Lease Liability USD 59,698 2023-01-01 2023-12-31 2024 FY 10-K 2025-03-28 0001013762-25-004108
us-gaap RoyaltyExpense Royalty Expense USD 5,000 2020-01-01 2020-12-31 2020 FY 10-K 2021-03-16 0001213900-21-015764
us-gaap SaleOfStockConsiderationReceivedPerTransaction Sale of Stock, Consideration Received Per Transaction USD 10.00M 2022-12-29 2024 FY 10-K 2025-03-28 0001013762-25-004108
us-gaap SaleOfStockNumberOfSharesIssuedInTransaction Sale of Stock, Number of Shares Issued in Transaction shares 2.86M 2026-04-01 2026 Q3 10-Q 2026-11-13 0001213900-26-119676
us-gaap SaleOfStockPricePerShare Sale of Stock, Price Per Share USD/shares 0.7 2026-04-01 2026 Q3 10-Q 2026-11-13 0001213900-26-119676
us-gaap SellingGeneralAndAdministrativeExpense Selling, General and Administrative Expense USD 450,313 2022-01-01 2022-06-30 2022 Q2 10-Q 2022-08-12 0001213900-22-047409
us-gaap ShareBasedCompensation Share-based Payment Arrangement, Noncash Expense USD 625,485 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001213900-26-119676
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueNonvested Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Nonvested USD 0 2023-09-30 2023 Q3 10-Q 2023-11-13 0001213900-23-086133
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Outstanding USD 132,090 2022-03-31 2022 Q1 10-Q 2022-05-12 0001213900-22-025987
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period shares 6.17M 2023-01-01 2023-12-31 2023 FY 10-K 2024-03-28 0001213900-24-027213
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value USD/shares 2.61 2023-01-01 2023-12-31 2023 FY 10-K 2024-03-28 0001213900-24-027213
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number shares 1,693 2024-03-31 2024 Q1 10-Q 2024-05-14 0001213900-24-042906
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value USD/shares 7.01 2023-12-31 2023 FY 10-K 2024-03-28 0001213900-24-027213
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period shares 1,791 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-31 0001213900-23-025455
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value USD/shares 7.17 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-31 0001213900-23-025455
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Exercise Price USD/shares 0.708 2026-09-30 2026 Q3 10-Q 2026-11-13 0001213900-26-119676
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate pure 0 2023-01-01 2023-01-03 2023 Q3 10-Q 2023-11-13 0001213900-23-086133
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate pure 1.208 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001213900-26-119676
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum pure 1.351 2023-01-01 2023-01-03 2023 Q3 10-Q 2023-11-13 0001213900-23-086133
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate pure 0.042 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001213900-26-119676
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum pure 0.039 2023-01-01 2023-01-03 2023 Q3 10-Q 2023-11-13 0001213900-23-086133
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Weighted Average Volatility Rate pure 1.2 2024-01-01 2024-06-30 2024 Q2 10-Q 2024-08-09 0001213900-24-067131
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant shares 83,738 2024-12-31 2024 FY 10-K 2025-03-28 0001013762-25-004108
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period shares 0 2026-01-01 2026-03-31 2026 Q1 10-Q 2026-05-15 0001213900-26-057726
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period shares 25,291 2023-01-01 2023-09-30 2023 Q3 10-Q 2023-11-13 0001213900-23-086133
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period shares 85,000 2020-01-01 2020-12-31 2021 FY 10-K 2022-03-30 0001213900-22-015909
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross shares 170,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-27 0001213900-26-035625
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value USD/shares 3.16 2022-01-01 2022-12-31 2023 FY 10-K 2024-03-28 0001213900-24-027213
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested, Number of Shares shares 1,693 2023-12-31 2023 FY 10-K 2024-03-28 0001213900-24-027213
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Option, Nonvested, Weighted Average Exercise Price USD/shares 3.16 2024-03-31 2024 Q1 10-Q 2024-05-14 0001213900-24-042906
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value USD 10,345 2026-09-30 2026 Q3 10-Q 2026-11-13 0001213900-26-119676
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number shares 2.31M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001213900-26-119676
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price USD/shares 2.69 2026-09-30 2026 Q3 10-Q 2026-11-13 0001213900-26-119676
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Aggregate Intrinsic Value USD 10,345 2026-09-30 2026 Q3 10-Q 2026-11-13 0001213900-26-119676
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Number shares 2.31M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001213900-26-119676
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Exercise Price USD/shares 2.69 2026-09-30 2026 Q3 10-Q 2026-11-13 0001213900-26-119676
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Number of Shares shares 1,691 2023-01-01 2023-12-31 2023 FY 10-K 2024-03-28 0001213900-24-027213
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Weighted Average Grant Date Fair Value USD/shares 3.16 2023-01-01 2023-12-31 2023 FY 10-K 2024-03-28 0001213900-24-027213
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Shares Issued in Period shares 1.05M 2026-05-26 2026 Q3 10-Q 2026-11-13 0001213900-26-119676
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price USD/shares 147 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-27 0001213900-26-035625
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price USD/shares 46.1 2023-01-01 2023-09-30 2023 Q3 10-Q 2023-11-13 0001213900-23-086133
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price USD/shares 1.55 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-27 0001213900-26-035625
us-gaap SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1 Share-based Payment Arrangement, Option, Exercise Price Range, Exercisable, Weighted Average Exercise Price USD/shares 4.78 2024-12-31 2024 FY 10-K 2025-03-28 0001013762-25-004108
us-gaap ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions Share-based Payment Arrangement, Option, Exercise Price Range, Shares Outstanding shares 2.31M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001213900-26-119676
us-gaap SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1 Share-based Payment Arrangement, Option, Exercise Price Range, Outstanding, Weighted Average Exercise Price USD/shares 2.69 2026-09-30 2026 Q3 10-Q 2026-11-13 0001213900-26-119676
us-gaap ShareBasedGoodsAndNonemployeeServicesTransactionTaxBenefit Share-based Goods and Nonemployee Services Transaction, Tax Benefit USD 22,141 2023-01-01 2023-09-30 2023 Q3 10-Q 2023-11-13 0001213900-23-086133
us-gaap SharePrice Share Price USD/shares 1.33 2026-06-10 2026 Q3 10-Q 2026-11-13 0001213900-26-119676
us-gaap SharesIssued Shares, Issued shares 79 2024-04-05 2024 Q1 10-Q 2024-05-14 0001213900-24-042906
us-gaap SharesIssuedPricePerShare Shares Issued, Price Per Share USD/shares 0.034 2025-09-23 2025 FY 10-K 2026-03-27 0001213900-26-035625
us-gaap SharesSubjectToMandatoryRedemptionSettlementTermsImpactOfChangesInFairValueOfSharesOnAmount Financial Instruments Subject to Mandatory Redemption, Settlement Terms, Impact of Changes in Fair Value of Shares on Amount USD 15,000 2018-01-31 2019 FY 10-K 2020-03-02 0001213900-20-005186
us-gaap ShorttermDebtFairValue Short-term Debt, Fair Value USD 591,090 2023-09-30 2023 Q3 10-Q 2023-11-13 0001213900-23-086133
us-gaap ShortTermLeaseCost Short-term Lease, Cost USD 16,010 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001213900-26-119676
us-gaap StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants Stock and Warrants Issued During Period, Value, Preferred Stock and Warrants USD 3.68M 2024-04-01 2024-06-30 2025 Q3 10-Q 2025-11-12 0001213900-25-109220
us-gaap StockholdersEquity Stockholders' Equity Attributable to Parent USD 7.42M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001213900-26-119676
us-gaap StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest USD 11.87M 2023-03-31 2023 Q1 10-Q 2023-05-15 0001213900-23-039789
us-gaap StockIssued1 Stock Issued USD 492,550 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001213900-26-119676
us-gaap StockIssuedDuringPeriodSharesEmployeeStockOwnershipPlan Stock Issued During Period, Shares, Employee Stock Ownership Plan shares 450,000 2024-01-01 2024-06-30 2024 Q2 10-Q 2024-08-09 0001213900-24-067131
us-gaap StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans Stock Issued During Period, Shares, Employee Stock Purchase Plans shares 310,744 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001213900-26-119676
us-gaap StockIssuedDuringPeriodSharesIssuedForServices Stock Issued During Period, Shares, Issued for Services shares 90,000 2023-01-01 2023-12-31 2023 FY 10-K 2024-03-28 0001213900-24-027213
us-gaap StockIssuedDuringPeriodSharesNewIssues Stock Issued During Period, Shares, New Issues shares 120,000 2026-06-10 2026 Q3 10-Q 2026-11-13 0001213900-26-119676
us-gaap StockIssuedDuringPeriodSharesOther Stock Issued During Period, Shares, Other shares 62,500 2017-08-02 2017-08-17 2018 FY 10-K 2019-04-01 0001213900-19-005307
us-gaap StockIssuedDuringPeriodSharesPurchaseOfAssets Stock Issued During Period, Shares, Purchase of Assets shares 2.50M 2022-12-01 2022-12-29 2023 FY 10-K 2024-03-28 0001213900-24-027213
us-gaap StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures Stock Issued During Period, Shares, Restricted Stock Award, Net of Forfeitures shares 37,500 2018-01-01 2018-12-31 2019 FY 10-K 2020-03-02 0001213900-20-005186
us-gaap StockIssuedDuringPeriodValueAcquisitions Stock Issued During Period, Value, Acquisitions USD 132,164 2018-01-01 2018-12-31 2019 FY 10-K 2020-03-02 0001213900-20-005186
us-gaap StockIssuedDuringPeriodValueConversionOfConvertibleSecurities Stock Issued During Period, Value, Conversion of Convertible Securities USD 1,000 2022-01-01 2022-12-31 2023 FY 10-K 2024-03-28 0001213900-24-027213
us-gaap StockIssuedDuringPeriodValueConversionOfUnits Stock Issued During Period, Value, Conversion of Units USD -10 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-31 0001213900-23-025455
us-gaap StockIssuedDuringPeriodValueIssuedForServices Stock Issued During Period, Value, Issued for Services USD 333,150 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-27 0001213900-26-035625
us-gaap StockIssuedDuringPeriodValueNewIssues Stock Issued During Period, Value, New Issues USD 1.90M 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001213900-26-119676
us-gaap StockIssuedDuringPeriodValueOther Stock Issued During Period, Value, Other USD 492,550 2026-04-01 2026-06-30 2026 Q3 10-Q 2026-11-13 0001213900-26-119676
us-gaap StockIssuedDuringPeriodValueRestrictedStockAwardGross Stock Issued During Period, Value, Restricted Stock Award, Gross USD 5.63M 2025-01-01 2025-03-31 2025 Q2 10-Q 2025-08-12 0001213900-25-074968
us-gaap StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures Stock Issued During Period, Value, Restricted Stock Award, Net of Forfeitures USD 38,000 2018-01-01 2018-12-31 2019 FY 10-K 2020-03-02 0001213900-20-005186
us-gaap StockIssuedDuringPeriodValueShareBasedCompensation Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture USD 216,428 2023-01-01 2023-12-31 2023 FY 10-K 2024-03-28 0001213900-24-027213
us-gaap StockIssuedDuringPeriodValueShareBasedCompensationGross Shares Issued, Value, Share-based Payment Arrangement, before Forfeiture USD 124,000 2021-01-01 2021-09-30 2022 Q3 10-Q 2022-11-10 0001213900-22-071279
us-gaap StockIssuedDuringPeriodValueStockOptionsExercised Stock Issued During Period, Value, Stock Options Exercised USD 495 2023-07-01 2023-09-30 2024 Q3 10-Q 2024-11-12 0001213900-24-096778
us-gaap StockIssuedDuringPeriodValueStockOptionsExercisedNetOfTaxBenefitExpense Stock Issued, Value, Stock Options Exercised, Net of Tax Benefit (Expense) USD 512,685 2024-01-01 2024-03-31 2024 Q1 10-Q 2024-05-14 0001213900-24-042906
us-gaap StockOptionExercisePriceIncrease Stock Option, Exercise Price, Increase USD/shares 1.678 2024-04-01 2024-04-30 2024 Q1 10-Q 2024-05-14 0001213900-24-042906
us-gaap StockRepurchasedDuringPeriodShares Stock Repurchased During Period, Shares shares 35,000 2020-01-01 2020-12-31 2020 FY 10-K 2021-03-16 0001213900-21-015764
us-gaap StockRepurchasedDuringPeriodValue Stock Repurchased During Period, Value USD 31,513 2018-01-01 2018-12-31 2018 FY 10-K 2019-04-01 0001213900-19-005307
us-gaap SupplementalDeferredPurchasePrice Supplemental Deferred Purchase Price USD 100,000 2020-05-28 2023 FY 10-K 2024-03-28 0001213900-24-027213
us-gaap TemporaryEquitySharesOutstanding Temporary Equity, Shares Outstanding shares 549,275 2023-09-13 2023 FY 10-K 2024-03-28 0001213900-24-027213
us-gaap UnrealizedGainLossOnDerivatives Unrealized Gain (Loss) on Derivatives USD 119,870 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-31 0001213900-23-025455
us-gaap UnrealizedGainLossOnInvestments Unrealized Gain (Loss) on Investments USD -567,692 2022-01-01 2022-12-31 2023 FY 10-K 2024-03-28 0001213900-24-027213
us-gaap ValuationAllowanceDeferredTaxAssetChangeInAmount Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount USD -548,660 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-30 0001213900-22-015909
us-gaap WarrantExercisePriceDecrease Warrant, Exercise Price, Decrease USD/shares 2.505 2023-09-01 2023-09-13 2023 FY 10-K 2024-03-28 0001213900-24-027213
us-gaap WarrantsAndRightsOutstanding Warrants and Rights Outstanding USD 550,500 2023-09-30 2024 Q1 10-Q 2024-05-14 0001213900-24-042906
us-gaap WeightedAverageNumberOfDilutedSharesOutstanding Weighted Average Number of Shares Outstanding, Diluted shares 20.38M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001213900-26-119676
us-gaap WeightedAverageNumberOfShareOutstandingBasicAndDiluted Weighted Average Number of Shares Outstanding, Basic and Diluted shares 22.33M 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-30 0001213900-22-015909
us-gaap WeightedAverageNumberOfSharesOutstandingBasic Weighted Average Number of Shares Outstanding, Basic shares 20.38M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001213900-26-119676

Financialist News Desk

Our desk turns official SEC filings into news. Each story is checked against the original filing. About us → · Editorial standards →